BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1391689 OC1CC(C1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |(-1.89,9.09,;-1.42,7.62,;-2.12,6.25,;-.74,5.55,;-.04,6.93,;-.27,4.09,;-1.17,2.84,;-.27,1.6,;1.2,2.07,;2.53,1.3,;3.86,2.07,;3.86,3.61,;2.53,4.38,;2.53,5.92,;1.2,6.69,;1.2,8.23,;2.53,9,;3.86,8.23,;3.86,6.69,;1.2,3.61,;5.2,1.3,;5.2,-.24,;6.53,2.07,;7.87,1.3,;7.87,-.24,;9.2,-1.01,;10.53,-.24,;11.87,-1.01,;13.2,-.24,;12.43,1.1,;13.97,-1.57,;14.53,.53,;10.53,1.3,;9.2,2.07,)| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-15(2-4-18)30-22(33)13-5-19(14-9-27-11-28-10-14)21-20(6-13)29-12-31(21)16-7-17(32)8-16/h1-6,9-12,16-17,32H,7-8H2,(H,30,33) DRLGQKRSNKZMSD-UHFFFAOYSA-N 661042 US20240101536, Example 2::US12454524, Example 2 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.370 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=661042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=661042&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458588 496709526 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391690 Cn1c(nc2c(cc(cc12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)-c1cncnc1)C(F)F InChI=1S/C21H14ClF4N5O2/c1-31-16-7-11(20(32)29-13-2-4-14(5-3-13)33-21(22,25)26)6-15(12-8-27-10-28-9-12)17(16)30-19(31)18(23)24/h2-10,18H,1H3,(H,29,32) JETJEHYPJBLXFI-UHFFFAOYSA-N 477662 US10889571, Example 3::US20240101536, Example 3::US12454524, Example 3 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.07 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477662 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477662&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458743 442137278 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391691 Cc1nc2c(cc(cc2n1C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)-c1cncnc1 InChI=1S/C21H16ClF2N5O2/c1-12-27-19-17(14-9-25-11-26-10-14)7-13(8-18(19)29(12)2)20(30)28-15-3-5-16(6-4-15)31-21(22,23)24/h3-11H,1-2H3,(H,28,30) VGPQMJXNYLLSOT-UHFFFAOYSA-N 477663 US10889571, Example 4::N-(4-(chlorodifluoromethoxy)phenyl)-1,2-dimethyl-4-(pyrimidin-5-yl)-1H-benzo[d]imidazole-6-carboxamide::US20240101536, Example 4::US12454524, Example 4 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.270 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477663&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458694 442137279 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391692 C[C@H](CO)n1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C23H18ClF4N5O3/c1-12(10-34)33-19-17(14-8-29-11-30-9-14)6-13(7-18(19)32-21(33)20(25)26)22(35)31-15-2-4-16(5-3-15)36-23(24,27)28/h2-9,11-12,20,34H,10H2,1H3,(H,31,35) MTFOIMMCUOJPHL-UHFFFAOYSA-N 477664 US10889571, Example 5::US20240101536, Example 5::US12454524, Example 5 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.380 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477664&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458745 442137280 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391693 CC(C)c1nc2cc(cc(-c3cncnc3)c2n1C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O2/c1-13(2)21-30-19-9-14(8-18(20(19)31(21)3)15-10-27-12-28-11-15)22(32)29-16-4-6-17(7-5-16)33-23(24,25)26/h4-13H,1-3H3,(H,29,32) BPTYRLPGNULGFL-UHFFFAOYSA-N 477665 US10889571, Example 6::US20240101536, Example 6::US12454524, Example 6 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.630 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477665&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458718 442137281 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391694 Cc1nc2cc(cc(-c3cncnc3)c2n1C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H16ClF2N5O2/c1-12-27-18-8-13(7-17(19(18)29(12)2)14-9-25-11-26-10-14)20(30)28-15-3-5-16(6-4-15)31-21(22,23)24/h3-11H,1-2H3,(H,28,30) HFAURYFAASRNNY-UHFFFAOYSA-N 477666 US10889571, Example 7::US20240101536, Example 7::US12454524, Example 7 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.330 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477666&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458647 442137282 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391695 COc1nc2cc(cc(-c3cncnc3)c2n1C(C)C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O3/c1-13(2)31-20-18(15-10-27-12-28-11-15)8-14(9-19(20)30-22(31)33-3)21(32)29-16-4-6-17(7-5-16)34-23(24,25)26/h4-13H,1-3H3,(H,29,32) GEPFJYUCXBQCNM-UHFFFAOYSA-N 477667 US10889571, Example 9::US20240101536, Example 9::US12454524, Example 9 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.330 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477667&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458713 442137283 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391696 CC(C)n1cnc2cc(cc(-n3cnc(c3)C3CC3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C24H22ClF2N5O2/c1-14(2)32-13-29-19-9-16(10-21(22(19)32)31-11-20(28-12-31)15-3-4-15)23(33)30-17-5-7-18(8-6-17)34-24(25,26)27/h5-15H,3-4H2,1-2H3,(H,30,33) SBZFQUARIANVKU-UHFFFAOYSA-N 477668 US10889571, Example 10::N-(4-(chlorodifluoromethoxy)phenyl)-7-(4-cyclopropyl-1H-imidazol-1-yl)-1-isopropyl-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 10::US12240835, Example 10::US12454524, Example 10 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.630 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477668&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458690 442137284 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391697 CC(C)n1cnc2cc(cc(Br)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C18H15BrClF2N3O2/c1-10(2)25-9-23-15-8-11(7-14(19)16(15)25)17(26)24-12-3-5-13(6-4-12)27-18(20,21)22/h3-10H,1-2H3,(H,24,26) JAKWLUZBLWZBPN-UHFFFAOYSA-N 477669 US10889571, Example 11::N-(4-(chlorodifluoromethoxy)phenyl)-7-(1H-imidazol-1-yl)-1-isopropyl-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 11 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.160 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477669&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458685 442137285 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391698 Cn1c(CCO)nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O3/c1-30-19(6-7-31)29-18-9-13(8-17(20(18)30)14-10-26-12-27-11-14)21(32)28-15-2-4-16(5-3-15)33-22(23,24)25/h2-5,8-12,31H,6-7H2,1H3,(H,28,32) ZXJIBJCAWIVZKM-UHFFFAOYSA-N 477670 US10889571, Example 12::N-(4-(chlorodifluoromethoxy)phenyl)-2-(2-hydroxyethyl)-1-methyl-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 12::US12240835, Example 12::US12454524, Example 12 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.380 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477670&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458676 442137286 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391699 CC(C)n1cnc2cc(cc(C(=O)NC3CC3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H21ClF2N4O3/c1-12(2)29-11-26-18-10-13(9-17(19(18)29)21(31)28-14-3-4-14)20(30)27-15-5-7-16(8-6-15)32-22(23,24)25/h5-12,14H,3-4H2,1-2H3,(H,27,30)(H,28,31) XXGBUISVYLIOKJ-UHFFFAOYSA-N 477671 US10889571, Example 13::N5-(4-(chlorodifluoromethoxy)phenyl)-N7-cyclopropyl-1-isopropyl-1H-benzo[d]imidazole-5,7-dicarboxamide::US20240101536, Example 13::US12240835, Example 13::US12454524, Example 13 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.710 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477671&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507801 442137287 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391700 OC1(Cn2cnc3cc(cc(-c4cncnc4)c23)C(=O)Nc2ccc(OC(F)(F)Cl)cc2)CC1 InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-17-3-1-16(2-4-17)30-21(32)14-7-18(15-9-27-12-28-10-15)20-19(8-14)29-13-31(20)11-22(33)5-6-22/h1-4,7-10,12-13,33H,5-6,11H2,(H,30,32) MRQBVRISEHOMOX-UHFFFAOYSA-N 477673 US10889571, Example 14::N-(4-(chlorodifluoromethoxy)phenyl)-1-(1-hydroxycyclopropyl)methyl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 14::US12240835, Example 14::US12454524, Example 14 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.860 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477673&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458747 442137289 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391701 FC(F)c1nc2cc(cc(-c3cncnc3)c2n1C1CC1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H16ClF4N5O2/c24-23(27,28)35-16-5-1-14(2-6-16)31-22(34)12-7-17(13-9-29-11-30-10-13)19-18(8-12)32-21(20(25)26)33(19)15-3-4-15/h1-2,5-11,15,20H,3-4H2,(H,31,34) IEIIUWGPESOFOG-UHFFFAOYSA-N 477674 US10889571, Example 15::N-(4-(chlorodifluoromethoxy)phenyl)-1-cyclopropyl-2-(difluoromethyl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 15::US12240835, Example 15::US12454524, Example 15 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.410 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477674 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477674&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458580 442137290 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391702 CC(C)(CO)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O3/c1-22(2,11-32)31-13-29-19-8-14(7-18(20(19)31)15-9-27-12-28-10-15)21(33)30-16-3-5-17(6-4-16)34-23(24,25)26/h3-10,12-13,32H,11H2,1-2H3,(H,30,33) BUIOQEKTHIJDML-UHFFFAOYSA-N 477675 US10889571, Example 16::N-(4-(chlorodifluoromethoxy)phenyl)-1-(1-hydroxy-2-methylpropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 16::US12240835, Example 16::US12454524, Example 16 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.580 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477675&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458657 442137291 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391703 CC(C)n1cnc2cc(cc(-c3[nH]ncc3F)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H17ClF3N5O2/c1-11(2)30-10-26-17-8-12(7-15(19(17)30)18-16(23)9-27-29-18)20(31)28-13-3-5-14(6-4-13)32-21(22,24)25/h3-11H,1-2H3,(H,27,29)(H,28,31) SSIBXEVTMOEUFN-UHFFFAOYSA-N 477676 US10889571, Example 17::N-(4-(chlorodifluoromethoxy)phenyl)-7-(4-fluoro-1H-pyrazol-5-yl)-1-isopropyl-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 17::US12240835, Example 17::US12454524, Example 17 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.340 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477676 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477676&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458677 442137292 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391704 COc1ccc(Cn2ncc(F)c2-c2cc(cc3ncn(C4CC4)c23)C(=O)Nc2ccc(OC(F)(F)Cl)cc2)cc1 |(-15.22,21.52,;-13.88,20.58,;-14.02,18.94,;-12.67,18,;-12.81,16.37,;-14.29,15.67,;-14.43,14.03,;-13.09,13.09,;-11.41,13.47,;-10.5,12.23,;-11.41,10.98,;-11.01,9.49,;-12.87,11.46,;-14.2,10.69,;-15.54,11.46,;-16.87,10.69,;-16.87,9.15,;-15.54,8.38,;-15.22,6.87,;-13.69,6.71,;-13.06,8.12,;-11.57,8.51,;-10.08,8.12,;-10.32,9.77,;-14.2,9.15,;-18.21,11.46,;-18.21,13,;-19.54,10.69,;-20.87,11.46,;-20.87,13,;-22.21,13.77,;-23.54,13,;-24.87,13.77,;-26.21,13,;-27.54,13.77,;-26.21,11.46,;-27.54,12.23,;-23.54,11.46,;-22.21,10.69,;-15.64,16.61,;-15.5,18.24,)| InChI=1S/C29H23ClF3N5O3/c1-40-21-8-2-17(3-9-21)15-38-26(24(31)14-35-38)23-12-18(13-25-27(23)37(16-34-25)20-6-7-20)28(39)36-19-4-10-22(11-5-19)41-29(30,32)33/h2-5,8-14,16,20H,6-7,15H2,1H3,(H,36,39) OGSIOSINNWFCFO-UHFFFAOYSA-N 477677 US10889571, Example 18::N-(4-(chlorodifluoromethoxy)phenyl)-1-cyclopropyl-7-(4-fluoro-1H-pyrazol-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 18 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.510 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477677&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458624 442137293 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391705 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)C2CS(=O)(=O)C2)cc1 InChI=1S/C22H16ClF2N5O4S/c23-22(24,25)34-17-3-1-15(2-4-17)29-21(31)13-5-18(14-7-26-11-27-8-14)20-19(6-13)28-12-30(20)16-9-35(32,33)10-16/h1-8,11-12,16H,9-10H2,(H,29,31) DZOXHVVFSMHCPW-UHFFFAOYSA-N 477678 US10889571, Example 19::N-(4-(chlorodifluoromethoxy)phenyl)-1-(1,1-dioxidothietan-3-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 19::US12240835, Example 19::US12454524, Example 19 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.02 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477678 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477678&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458633 442137294 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391706 CC(C)n1cnc2cc(C(=O)Nc3ccc(OC(F)(F)Cl)cc3)c(F)c(-c3cncnc3)c12 InChI=1S/C22H17ClF3N5O2/c1-12(2)31-11-29-17-7-16(19(24)18(20(17)31)13-8-27-10-28-9-13)21(32)30-14-3-5-15(6-4-14)33-22(23,25)26/h3-12H,1-2H3,(H,30,32) QKCXROWMDRAVTL-UHFFFAOYSA-N 477679 US10889571, Example 20::N-(4-(chlorodifluoromethoxy)phenyl)-6-fluoro-1-isopropyl-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 20::US12240835, Example 20::US12454524, Example 20 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.500 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477679&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458700 442137295 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391707 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(CC(=O)NC4CC4)cnc3c2)cc1 InChI=1S/C24H19ClF2N6O3/c25-24(26,27)36-18-5-3-17(4-6-18)32-23(35)14-7-19(15-9-28-12-29-10-15)22-20(8-14)30-13-33(22)11-21(34)31-16-1-2-16/h3-10,12-13,16H,1-2,11H2,(H,31,34)(H,32,35) ZNHNDPPZXABNOW-UHFFFAOYSA-N 477680 US10889571, Example 21::N-(4-(chlorodifluoromethoxy)phenyl)-1-(2-(cyclopropylamino)-2-oxoethyl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 21::US12454524, Example 21 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.640 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477680 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477680&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458635 442137296 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391708 CC(C)n1cnc2cc(cc(-c3cscn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H17ClF2N4O2S/c1-12(2)28-10-25-17-8-13(7-16(19(17)28)18-9-31-11-26-18)20(29)27-14-3-5-15(6-4-14)30-21(22,23)24/h3-12H,1-2H3,(H,27,29) NIOLDGWHUZUZPQ-UHFFFAOYSA-N 477681 US10889571, Example 22::US20240101536, Example 22::US12454524, Example 22 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.310 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477681&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458765 442137297 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391709 COc1ccc(CNc2cc(cc3ncn(C(C)C)c23)C(=O)Nc2ccc(OC(F)(F)Cl)cc2)cc1 InChI=1S/C26H25ClF2N4O3/c1-16(2)33-15-31-23-13-18(25(34)32-19-6-10-21(11-7-19)36-26(27,28)29)12-22(24(23)33)30-14-17-4-8-20(35-3)9-5-17/h4-13,15-16,30H,14H2,1-3H3,(H,32,34) NYMOERNQPUCMBF-UHFFFAOYSA-N 477682 US10889571, Example 23::N-(4-(chlorodifluoromethoxy)phenyl)-1-isopropyl-7-(4H-1,2,4-triazol-4-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 23 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.720 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477682&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458670 442137298 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391710 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)[C@@H]2CNC(=O)C2)cc1 InChI=1S/C23H17ClF2N6O3/c24-23(25,26)35-17-3-1-15(2-4-17)31-22(34)13-5-18(14-8-27-11-28-9-14)21-19(6-13)30-12-32(21)16-7-20(33)29-10-16/h1-6,8-9,11-12,16H,7,10H2,(H,29,33)(H,31,34) CZOIQQDHLUKMSV-UHFFFAOYSA-N 477683 US10889571, Example 24::US20240101536, Example 24::US12454524, Example 24 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.400 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477683&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458709 442137299 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391711 CC(C)n1cnc2cc(cc(-c3noc(=O)[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C20H16ClF2N5O4/c1-10(2)28-9-24-15-8-11(7-14(16(15)28)17-26-19(30)32-27-17)18(29)25-12-3-5-13(6-4-12)31-20(21,22)23/h3-10H,1-2H3,(H,25,29)(H,26,27,30) WELMQGYYKWQVML-UHFFFAOYSA-N 477684 US10889571, Example 25::N-(4-(chlorodifluoromethoxy)phenyl)-1-isopropyl-7-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-benzo[d]imidazole-5-carboxamide::US20240101536, Example 25::US12240835, Example 25::US12454524, Example 25 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 20.7 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477684&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 156027070 442137300 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391712 CC(C)n1cnc2cc(cc(C(N)=O)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C19H17ClF2N4O3/c1-10(2)26-9-24-15-8-11(7-14(16(15)26)17(23)27)18(28)25-12-3-5-13(6-4-12)29-19(20,21)22/h3-10H,1-2H3,(H2,23,27)(H,25,28) RIPACNUQSZQTSH-UHFFFAOYSA-N 477685 US10889571, Example 26::N5-(4-(chlorodifluoromethoxy)phenyl)-1-isopropyl-1H-benzo[d]imidazole-5,7-dicarboxamide::US20240101536, Example 26::US12240835, Example 26::US12454524, Example 26 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 2.31 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477685&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507799 442137301 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391713 CC(C)n1cnc2cc(nc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H17ClF2N6O2/c1-12(2)30-11-27-16-7-17(29-18(19(16)30)13-8-25-10-26-9-13)20(31)28-14-3-5-15(6-4-14)32-21(22,23)24/h3-12H,1-2H3,(H,28,31) LWVVQTLKSONZQB-UHFFFAOYSA-N 477686 US10889571, Example 27::N-(4-(chlorodifluoromethoxy)phenyl)-3-isopropyl-4-(pyrimidin-5-yl)-3H-imidazo[4,5-c]pyridine-6-carboxamide::US20240101536, Example 27::US12240835, Example 27::US12454524, Example 27 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 4.78 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477686&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458687 442137302 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391714 C[C@H](CF)n1c(nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C22H17ClF5N5O2/c1-11(10-24)33-18-15(16-6-7-29-32-16)8-12(9-17(18)31-20(33)19(25)26)21(34)30-13-2-4-14(5-3-13)35-22(23,27)28/h2-9,11,19H,10H2,1H3,(H,29,32)(H,30,34) FQWJQIWICAZVNL-UHFFFAOYSA-N 477687 US10889571, Example 28::US20240101536, Example 28::US12240835, Example 28::US12454524, Example 28 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.570 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477687&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458682 442137303 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391715 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(Br)c3n4CCS(=O)(=O)Cc4nc3c2)cc1 InChI=1S/C18H13BrClF2N3O4S/c19-13-7-10(8-14-16(13)25-5-6-30(27,28)9-15(25)24-14)17(26)23-11-1-3-12(4-2-11)29-18(20,21)22/h1-4,7-8H,5-6,9H2,(H,23,26) IXGISCZBVGBWTL-UHFFFAOYSA-N 477688 US10889571, Example 29::N-(4-(chlorodifluoromethoxy)phenyl)-6-(pyrimidin-5-yl)-3,4-dihydro-1H-benzo[4,5]imidazo[2,1-c][1,4]thiazine-8-carboxamide 2,2-dioxide::US20240101536, Example 29 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.620 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477688&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458754 442137304 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391716 CC(C)n1cnc2cc(cc(-c3cnn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C20H17ClF2N6O2/c1-11(2)29-10-24-16-8-12(7-15(18(16)29)17-9-25-28-27-17)19(30)26-13-3-5-14(6-4-13)31-20(21,22)23/h3-11H,1-2H3,(H,26,30)(H,25,27,28) CHYYKDXOOPAFES-UHFFFAOYSA-N 477689 US10889571, Example 30::US20240101536, Example 30::US12240835, Example 30::US12454524, Example 30 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.800 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477689&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458612 442137305 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391717 CC(C)n1cnc2cc(cc(-c3n[nH]cc3C#N)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H17ClF2N6O2/c1-12(2)31-11-27-18-8-13(7-17(20(18)31)19-14(9-26)10-28-30-19)21(32)29-15-3-5-16(6-4-15)33-22(23,24)25/h3-8,10-12H,1-2H3,(H,28,30)(H,29,32) OQWNETGKVYQEAX-UHFFFAOYSA-N 477690 US10889571, Example 31::US20240101536, Example 31::US12240835, Example 31::US12454524, Example 31 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.660 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477690 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477690&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458744 442137306 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391718 CNC(=O)c3cc(C(=O)Nc1ccc(OC(F)(F)Cl)cc1)cc4nc2COC[C@@H](C)n2c34 InChI=1S/C21H19ClF2N4O4/c1-11-9-31-10-17-27-16-8-12(7-15(20(30)25-2)18(16)28(11)17)19(29)26-13-3-5-14(6-4-13)32-21(22,23)24/h3-8,11H,9-10H2,1-2H3,(H,25,30)(H,26,29) RHFBMILGABCZCY-UHFFFAOYSA-N 477691 US10889571, Example 32::(R)—N8-(4-(chlorodifluoromethoxy)phenyl)-N6,4-dimethyl-3,4-dihydro-1H-benzo[4,5]imidazo[2,1-c][1,4]oxazine-6,8-dicarboxamide::US20240101536, Example 32::US12454524, Example 32 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.370 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477691&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458704 442137307 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391719 C[C@@H]1COc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H16ClF2N5O3/c1-11-10-31-20-27-17-9-12(8-15(18(17)29(11)20)16-6-7-25-28-16)19(30)26-13-2-4-14(5-3-13)32-21(22,23)24/h2-9,11H,10H2,1H3,(H,25,28)(H,26,30) UFHSSMRCIIODQR-UHFFFAOYSA-N 477692 US10889571, Example 33::US20240101536, Example 33::US12454524, Example 33 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.600 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477692&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458585 442137308 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391720 OC[C@@H]1COCc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O4/c23-22(24,25)34-15-3-1-13(2-4-15)27-21(32)12-7-16(17-5-6-26-29-17)20-18(8-12)28-19-11-33-10-14(9-31)30(19)20/h1-8,14,31H,9-11H2,(H,26,29)(H,27,32) GQDODWWKUPWRFW-UHFFFAOYSA-N 477693 US10889571, Example 34::US20240101536, Example 34::US12454524, Example 34 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.740 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477693&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458727 442137309 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391721 FC[C@@H]1COCc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF3N5O3/c23-22(25,26)34-15-3-1-13(2-4-15)28-21(32)12-7-16(17-5-6-27-30-17)20-18(8-12)29-19-11-33-10-14(9-24)31(19)20/h1-8,14H,9-11H2,(H,27,30)(H,28,32) CIQDEABWTSYZQB-UHFFFAOYSA-N 477694 US10889571, Example 35::(S)—N-(4-(chlorodifluoromethoxy)phenyl)-4-(fluoromethyl)-6-(1H-pyrazol-5-yl)-3,4-dihydro-1H-benzo[4,5]imidazo[2,1-c][1,4]oxazine-8-carboxamide::US20240101536, Example 35::US12240835, Example 35::US12454524, Example 35 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.320 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477694&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458573 442137310 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391722 C[C@@H]1COCc2nc3cc(cc(N4CC(O)C4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H21ClF2N4O4/c1-12-10-32-11-19-27-17-6-13(7-18(20(17)29(12)19)28-8-15(30)9-28)21(31)26-14-2-4-16(5-3-14)33-22(23,24)25/h2-7,12,15,30H,8-11H2,1H3,(H,26,31) PHWCXTHGBBBBRV-UHFFFAOYSA-N 661944 US10889571, Example 36::US20240101536, Example 36::US12240835, Example 36::US12454524, Example 36 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 4.20 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=661944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=661944&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458721 496710412 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391723 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3ccn[nH]3)c3n4CCCCc4nc3c2)cc1 InChI=1S/C22H18ClF2N5O2/c23-22(24,25)32-15-6-4-14(5-7-15)27-21(31)13-11-16(17-8-9-26-29-17)20-18(12-13)28-19-3-1-2-10-30(19)20/h4-9,11-12H,1-3,10H2,(H,26,29)(H,27,31) YNNLHGZKHWLMGW-UHFFFAOYSA-N 477696 US10889571, Example 37::N-(4-(chlorodifluoromethoxy)phenyl)-9-(1H-pyrazol-5-yl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-7-carboxamide::US20240101536, Example 37::US12240835, Example 37::US12454524, Example 37 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.540 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477696&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458577 442137311 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391724 O[C@@H]1CCCn2c1nc1cc(cc(-c3ccn[nH]3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O3/c23-22(24,25)33-14-5-3-13(4-6-14)27-21(32)12-10-15(16-7-8-26-29-16)19-17(11-12)28-20-18(31)2-1-9-30(19)20/h3-8,10-11,18,31H,1-2,9H2,(H,26,29)(H,27,32) RQGWLSGIZDXUSB-UHFFFAOYSA-N 477697 US10889571, Example 38::US20240101536, Example 38::US12454524, Example 38 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.630 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477697&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458661 442137312 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391725 C[C@@H]1COCc2nc3cc(cc(-c4cc(O)ccn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C24H19ClF2N4O4/c1-13-11-34-12-21-30-20-9-14(8-18(22(20)31(13)21)19-10-16(32)6-7-28-19)23(33)29-15-2-4-17(5-3-15)35-24(25,26)27/h2-10,13H,11-12H2,1H3,(H,28,32)(H,29,33) ZGQXTHABPBZALK-UHFFFAOYSA-N 477698 US10889571, Example 39::US20240101536, Example 39::US12454524, Example 39 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.11 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477698&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458656 442137313 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391726 C[C@H](O)c1nc2cc(cc(-c3ccn[nH]3)c2n1C(C)C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H22ClF2N5O3/c1-12(2)31-20-17(18-8-9-27-30-18)10-14(11-19(20)29-21(31)13(3)32)22(33)28-15-4-6-16(7-5-15)34-23(24,25)26/h4-13,32H,1-3H3,(H,27,30)(H,28,33) ZGTQWBTZDSRSME-UHFFFAOYSA-N 477699 US10889571, Example 40::US20240101536, Example 40::US12240835, Example 40::US12454524, Example 40 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477699&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458583 442137314 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391727 C[C@@H]1COCc2nc3cc(cc(N4CCCC4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H23ClF2N4O3/c1-14-12-32-13-20-28-18-10-15(11-19(21(18)30(14)20)29-8-2-3-9-29)22(31)27-16-4-6-17(7-5-16)33-23(24,25)26/h4-7,10-11,14H,2-3,8-9,12-13H2,1H3,(H,27,31) XDUWBIQBEKNHAB-UHFFFAOYSA-N 661945 US10889571, Example 41::US20240101536, Example 41::US12240835, Example 41::US12454524, Example 41 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 281 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=661945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=661945&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458679 496710413 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391728 C[C@@H]1COc2nc3cc(cc(-c4cccnn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H16ClF2N5O3/c1-12-11-32-21-28-18-10-13(9-16(19(18)30(12)21)17-3-2-8-26-29-17)20(31)27-14-4-6-15(7-5-14)33-22(23,24)25/h2-10,12H,11H2,1H3,(H,27,31) NEIXOEOTOUWAOI-UHFFFAOYSA-N 477701 US10889571, Example 42::US20240101536, Example 42::US12454524, Example 42 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.560 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477701&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458702 442137315 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391729 O[C@H]1CCc2nc3cc(cc(-c4cncnc4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-17-4-1-15(2-5-17)29-22(33)13-7-18(14-9-27-12-28-10-14)21-19(8-13)30-20-6-3-16(32)11-31(20)21/h1-2,4-5,7-10,12,16,32H,3,6,11H2,(H,29,33) QHBDVGWSYYEMNY-UHFFFAOYSA-N 477702 US10889571, Example 43::US20240101536, Example 43::US12454524, Example 43 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.380 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477702&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458757 442137316 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391730 O[C@@H]1COc2nc3cc(cc(-c4ccn[nH]4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H16ClF2N5O4/c22-21(23,24)33-14-3-1-12(2-4-14)26-19(31)11-7-15(16-5-6-25-28-16)18-17(8-11)27-20-29(18)9-13(30)10-32-20/h1-8,13,30H,9-10H2,(H,25,28)(H,26,31) JINCZJLUPRREFO-UHFFFAOYSA-N 477703 US10889571, Example 44::US20240101536, Example 44::US12454524, Example 44 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.650 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477703&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458673 442137317 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391731 OC[C@@H]1CCOc2nc3cc(cc(-c4cccnn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-16-5-3-14(4-6-16)28-21(33)13-10-17(18-2-1-8-27-30-18)20-19(11-13)29-22-31(20)15(12-32)7-9-34-22/h1-6,8,10-11,15,32H,7,9,12H2,(H,28,33) GMGHMURUPSKSAC-UHFFFAOYSA-N 477704 US10889571, Example 45::US20240101536, Example 45::US12454524, Example 45 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.410 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477704&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458651 442137318 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391732 O[C@@H]1CCCn2c1nc1cc(cc(-c3cccnn3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-15-7-5-14(6-8-15)28-22(33)13-11-16(17-3-1-9-27-30-17)20-18(12-13)29-21-19(32)4-2-10-31(20)21/h1,3,5-9,11-12,19,32H,2,4,10H2,(H,28,33) DYGAAAGPEQGAEB-UHFFFAOYSA-N 661085 (R)—N-(4-(chlorodifluoromethoxy)phenyl)-4-hydroxy-9-(pyridazin-3-yl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-7-carboxamide::US20240101536, Example 46::US12454524, Example 46 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.670 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=661085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=661085&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458605 496709568 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391733 C[C@H]1[C@@H](CO)Oc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O4/c1-11-18(10-31)33-21-28-17-9-12(8-15(19(17)30(11)21)16-6-7-26-29-16)20(32)27-13-2-4-14(5-3-13)34-22(23,24)25/h2-9,11,18,31H,10H2,1H3,(H,26,29)(H,27,32) OMFCHJDSVYLXIE-UHFFFAOYSA-N 477707 US10889571, Example 47::(2S,3S)—N-(4-(chlorodifluoromethoxy)phenyl)-2-(hydroxymethyl)-3-methyl-5-(1H-pyrazol-5-yl)-2,3-dihydrobenzo[4,5]imidazo[2,1-b]oxazole-7-carboxamide::US20240101536, Example 47::US12240835, Example 47::US12454524, Example 47 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 3.17 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477707&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458675 442137321 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391734 C[C@]1(O)CCc2nc3cc(cc(-c4ccn[nH]4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O3/c1-22(33)8-6-19-29-18-11-13(10-16(17-7-9-27-30-17)20(18)31(19)12-22)21(32)28-14-2-4-15(5-3-14)34-23(24,25)26/h2-5,7,9-11,33H,6,8,12H2,1H3,(H,27,30)(H,28,32) KAOLEVWLFXERDQ-UHFFFAOYSA-N 477708 US10889571, Example 48::(S)—N-(4-(chlorodifluoromethoxy)phenyl)-2-hydroxy-2-methyl-9-(1H-pyrazol-5-yl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyridine-7-carboxamide::US20240101536, Example 48::US12240835, Example 48::US12454524, Example 48 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.30 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477708&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458764 442137322 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391735 CC(C)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O2/c1-13(2)30-12-28-19-8-14(7-18(20(19)30)15-9-26-11-27-10-15)21(31)29-16-3-5-17(6-4-16)32-22(23,24)25/h3-13H,1-2H3,(H,29,31) AXNWCCPLNXNTHT-UHFFFAOYSA-N 477709 US10889571, Example 50::US20240101536, Example 50::US12240835, Example 50::US12454524, Example 50 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.270 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477709&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509054 442137323 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391736 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)C2CC2)cc1 InChI=1S/C22H16ClF2N5O2/c23-22(24,25)32-17-5-1-15(2-6-17)29-21(31)13-7-18(14-9-26-11-27-10-14)20-19(8-13)28-12-30(20)16-3-4-16/h1-2,5-12,16H,3-4H2,(H,29,31) PECGVDICVCERQT-UHFFFAOYSA-N 477710 US10889571, Example 51::US20240101536, Example 51::US12240835, Example 51::US12454524, Example 51 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.260 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477710&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509056 442137324 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391737 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)C2CCC2)cc1 InChI=1S/C23H18ClF2N5O2/c24-23(25,26)33-18-6-4-16(5-7-18)30-22(32)14-8-19(15-10-27-12-28-11-15)21-20(9-14)29-13-31(21)17-2-1-3-17/h4-13,17H,1-3H2,(H,30,32) OYKVNLWRAWGKNA-UHFFFAOYSA-N 477711 US10889571, Example 52::US20240101536, Example 52::US12240835, Example 52::US12454524, Example 52 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.370 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477711&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507809 442137325 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391738 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)C2CCOC2)cc1 InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-16(2-4-18)30-22(32)14-7-19(15-9-27-12-28-10-15)21-20(8-14)29-13-31(21)17-5-6-33-11-17/h1-4,7-10,12-13,17H,5-6,11H2,(H,30,32) SPSDCHATWMDHKN-UHFFFAOYSA-N 477712 US10889571, Example 53::US20240101536, Example 53::US12240835, Example 53::US12454524, Example 53 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.540 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477712&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507896 442137326 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391739 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)C2CCCC2)cc1 InChI=1S/C24H20ClF2N5O2/c25-24(26,27)34-19-7-5-17(6-8-19)31-23(33)15-9-20(16-11-28-13-29-12-16)22-21(10-15)30-14-32(22)18-3-1-2-4-18/h5-14,18H,1-4H2,(H,31,33) TWAIYIQSVFQDHP-UHFFFAOYSA-N 477713 US10889571, Example 54::US20240101536, Example 54::US12240835, Example 54::US12454524, Example 54 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.510 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477713&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507821 442137327 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391740 C[C@H](CF)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF3N5O2/c1-13(8-24)31-12-29-19-7-14(6-18(20(19)31)15-9-27-11-28-10-15)21(32)30-16-2-4-17(5-3-16)33-22(23,25)26/h2-7,9-13H,8H2,1H3,(H,30,32) QCHBQPUGAKEWCE-UHFFFAOYSA-N 477714 US10889571, Example 58::US20240101536, Example 58::US12240835, Example 58::US12454524, Example 58 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.430 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477714 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477714&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508262 442137328 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391741 C[C@@H](CO)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-13(10-31)30-12-28-19-7-14(6-18(20(19)30)15-8-26-11-27-9-15)21(32)29-16-2-4-17(5-3-16)33-22(23,24)25/h2-9,11-13,31H,10H2,1H3,(H,29,32) PRTQTTBBMUXAQF-UHFFFAOYSA-N 477715 US10889571, Example 59::US20240101536, Example 59::US12240835, Example 59::US12454524, Example 59 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.470 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477715&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507807 442137329 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391742 C[C@H](CO)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-13(10-31)30-12-28-19-7-14(6-18(20(19)30)15-8-26-11-27-9-15)21(32)29-16-2-4-17(5-3-16)33-22(23,24)25/h2-9,11-13,31H,10H2,1H3,(H,29,32) PRTQTTBBMUXAQF-UHFFFAOYSA-N 477716 US10889571, Example 60::US20240101536, Example 60::US12240835, Example 60::US12454524, Example 60 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477716 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477716&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508266 442137330 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391743 F[C@H]1C[C@H](C1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r,wU:3.5,1.0,(9.78,-.76,;8.29,-1.16,;7.52,-2.49,;6.19,-1.72,;6.96,-.39,;4.7,-2.12,;4.07,-3.53,;2.54,-3.37,;2.22,-1.86,;.89,-1.09,;.89,.45,;2.22,1.22,;3.56,.45,;4.89,1.22,;6.22,.45,;7.56,1.22,;7.56,2.76,;6.22,3.53,;4.89,2.76,;3.56,-1.09,;-.44,1.22,;-.44,2.76,;-1.78,.45,;-3.11,1.22,;-4.45,.45,;-5.78,1.22,;-5.78,2.76,;-7.11,3.53,;-8.45,2.76,;-9.78,3.53,;-8.45,1.22,;-9.78,1.99,;-4.45,3.53,;-3.11,2.76,)| InChI=1S/C23H17ClF3N5O2/c24-23(26,27)34-18-3-1-16(2-4-18)31-22(33)13-5-19(14-9-28-11-29-10-14)21-20(6-13)30-12-32(21)17-7-15(25)8-17/h1-6,9-12,15,17H,7-8H2,(H,31,33) MFIBCUZHCTYCHQ-UHFFFAOYSA-N 477717 US10889571, Example 61::US20240101536, Example 61::US12240835, Example 61::US12454524, Example 61 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.470 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477717&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507796 442137331 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391744 F[C@H]1C[C@@H](C1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r,wU:3.5,wD:1.0,(9.78,-.76,;8.29,-1.16,;6.96,-.39,;6.19,-1.72,;7.52,-2.49,;4.7,-2.12,;4.07,-3.53,;2.54,-3.37,;2.22,-1.86,;.89,-1.09,;.89,.45,;2.22,1.22,;3.56,.45,;4.89,1.22,;6.22,.45,;7.56,1.22,;7.56,2.76,;6.22,3.53,;4.89,2.76,;3.56,-1.09,;-.44,1.22,;-.44,2.76,;-1.78,.45,;-3.11,1.22,;-4.45,.45,;-5.78,1.22,;-5.78,2.76,;-7.11,3.53,;-8.45,2.76,;-9.78,3.53,;-8.45,1.22,;-9.78,1.99,;-4.45,3.53,;-3.11,2.76,)| InChI=1S/C23H17ClF3N5O2/c24-23(26,27)34-18-3-1-16(2-4-18)31-22(33)13-5-19(14-9-28-11-29-10-14)21-20(6-13)30-12-32(21)17-7-15(25)8-17/h1-6,9-12,15,17H,7-8H2,(H,31,33) MFIBCUZHCTYCHQ-UHFFFAOYSA-N 477718 US10889571, Example 62::US20240101536, Example 62::US12240835, Example 62::US12454524, Example 62 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.450 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477718 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477718&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507796 442137332 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391745 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(CC4CC4)cnc3c2)cc1 InChI=1S/C23H18ClF2N5O2/c24-23(25,26)33-18-5-3-17(4-6-18)30-22(32)15-7-19(16-9-27-12-28-10-16)21-20(8-15)29-13-31(21)11-14-1-2-14/h3-10,12-14H,1-2,11H2,(H,30,32) FRLFYSHRFQXXGA-UHFFFAOYSA-N 477719 US10889571, Example 63::US20240101536, Example 63::US12240835, Example 63::US12454524, Example 63 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.590 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477719&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508261 442137333 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391746 COC[C@@H](C)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O3/c1-14(11-33-2)31-13-29-20-8-15(7-19(21(20)31)16-9-27-12-28-10-16)22(32)30-17-3-5-18(6-4-17)34-23(24,25)26/h3-10,12-14H,11H2,1-2H3,(H,30,32) CHEWGTPWZMEDRP-UHFFFAOYSA-N 477720 US10889571, Example 64::US20240101536, Example 64::US12240835, Example 64::US12454524, Example 64 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477720&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508258 442137334 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391747 COC[C@H](C)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O3/c1-14(11-33-2)31-13-29-20-8-15(7-19(21(20)31)16-9-27-12-28-10-16)22(32)30-17-3-5-18(6-4-17)34-23(24,25)26/h3-10,12-14H,11H2,1-2H3,(H,30,32) CHEWGTPWZMEDRP-UHFFFAOYSA-N 477721 US10889571, Example 65::US20240101536, Example 65::US12240835, Example 65::US12454524, Example 65 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.770 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477721&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507803 442137335 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391748 C[C@H](n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(C)(C)O |r| InChI=1S/C24H22ClF2N5O3/c1-14(23(2,3)34)32-13-30-20-9-15(8-19(21(20)32)16-10-28-12-29-11-16)22(33)31-17-4-6-18(7-5-17)35-24(25,26)27/h4-14,34H,1-3H3,(H,31,33) CMSGQHMTXSNXJD-UHFFFAOYSA-N 477722 US10889571, Example 66::US20240101536, Example 66::US12240835, Example 66::US12454524, Example 66 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.560 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477722&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508255 442137336 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391749 O[C@@H]1CCC1n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-16-3-1-15(2-4-16)30-22(33)13-7-17(14-9-27-11-28-10-14)21-18(8-13)29-12-31(21)19-5-6-20(19)32/h1-4,7-12,19-20,32H,5-6H2,(H,30,33) JMPFPFUKFFDTKH-UHFFFAOYSA-N 477723 US10889571, Example 67::US20240101536, Example 67::US12240835, Example 67::US12454524, Example 67 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.610 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477723 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477723&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 153465055 442137337 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391750 CC(C)(O)Cn1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O3/c1-22(2,33)11-31-13-29-19-8-14(7-18(20(19)31)15-9-27-12-28-10-15)21(32)30-16-3-5-17(6-4-16)34-23(24,25)26/h3-10,12-13,33H,11H2,1-2H3,(H,30,32) BGFLXSUVLRYWKQ-UHFFFAOYSA-N 477724 US10889571, Example 68::US20240101536, Example 68::US12240835, Example 68::US12454524, Example 68 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.21 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477724&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507900 442137338 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391751 C[C@@H](CF)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF3N5O2/c1-13(8-24)31-12-29-19-7-14(6-18(20(19)31)15-9-27-11-28-10-15)21(32)30-16-2-4-17(5-3-16)33-22(23,25)26/h2-7,9-13H,8H2,1H3,(H,30,32) QCHBQPUGAKEWCE-UHFFFAOYSA-N 477725 US10889571, Example 69::US20240101536, Example 69::US12240835, Example 69::US12454524, Example 69 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.490 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477725&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507804 442137339 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391752 C[C@@H]1C[C@H]1n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O2/c1-13-6-20(13)31-12-29-19-8-14(7-18(21(19)31)15-9-27-11-28-10-15)22(32)30-16-2-4-17(5-3-16)33-23(24,25)26/h2-5,7-13,20H,6H2,1H3,(H,30,32) NUWCYVOYDIKWBD-UHFFFAOYSA-N 477726 US10889571, Example 70::US20240101536, Example 70::US12240835, Example 70::US12454524, Example 70 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.390 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477726&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507902 442137340 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391753 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(C[C@H]4CCCO4)cnc3c2)cc1 |r| InChI=1S/C24H20ClF2N5O3/c25-24(26,27)35-18-5-3-17(4-6-18)31-23(33)15-8-20(16-10-28-13-29-11-16)22-21(9-15)30-14-32(22)12-19-2-1-7-34-19/h3-6,8-11,13-14,19H,1-2,7,12H2,(H,31,33) QVNODPWRHPKDGH-UHFFFAOYSA-N 477727 US10889571, Example 71::US20240101536, Example 71::US12240835, Example 71::US12454524, Example 71 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.780 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477727 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477727&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508264 442137341 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391754 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3[nH]cnc3c2)cc1 InChI=1S/C19H12ClF2N5O2/c20-19(21,22)29-14-3-1-13(2-4-14)27-18(28)11-5-15(12-7-23-9-24-8-12)17-16(6-11)25-10-26-17/h1-10H,(H,25,26)(H,27,28) RYFDOQYQYVGHPN-UHFFFAOYSA-N 477728 US10889571, Example 72::US20240101536, Example 72::US12240835, Example 72::US12454524, Example 72 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.790 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477728 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477728&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507823 442137342 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391755 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(C[C@@H]4CCCO4)cnc3c2)cc1 |r| InChI=1S/C24H20ClF2N5O3/c25-24(26,27)35-18-5-3-17(4-6-18)31-23(33)15-8-20(16-10-28-13-29-11-16)22-21(9-15)30-14-32(22)12-19-2-1-7-34-19/h3-6,8-11,13-14,19H,1-2,7,12H2,(H,31,33) QVNODPWRHPKDGH-UHFFFAOYSA-N 477729 US10889571, Example 73::US20240101536, Example 73::US12240835, Example 73::US12454524, Example 73 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.830 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477729 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477729&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507893 442137343 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391756 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)[C@@H]2CCOC2)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-16(2-4-18)30-22(32)14-7-19(15-9-27-12-28-10-15)21-20(8-14)29-13-31(21)17-5-6-33-11-17/h1-4,7-10,12-13,17H,5-6,11H2,(H,30,32) SPSDCHATWMDHKN-UHFFFAOYSA-N 477730 US10889571, Example 74::US20240101536, Example 74::US12240835, Example 74::US12454524, Example 74 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.320 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477730 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477730&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507808 442137344 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391757 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)[C@H]2CCOC2)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-16(2-4-18)30-22(32)14-7-19(15-9-27-12-28-10-15)21-20(8-14)29-13-31(21)17-5-6-33-11-17/h1-4,7-10,12-13,17H,5-6,11H2,(H,30,32) SPSDCHATWMDHKN-UHFFFAOYSA-N 477731 US10889571, Example 75::US20240101536, Example 75::US12240835, Example 75::US12454524, Example 75 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.410 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477731 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477731&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507806 442137345 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391758 C[C@H]1OCC[C@H]1n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C24H20ClF2N5O3/c1-14-21(6-7-34-14)32-13-30-20-9-15(8-19(22(20)32)16-10-28-12-29-11-16)23(33)31-17-2-4-18(5-3-17)35-24(25,26)27/h2-5,8-14,21H,6-7H2,1H3,(H,31,33) XOSXTEJCPXIBOV-UHFFFAOYSA-N 477732 US10889571, Example 76::US20240101536, Example 76::US12240835, Example 76::US12454524, Example 76 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.550 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477732&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507826 442137346 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391759 O[C@@H]1COC[C@@H]1n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-16-3-1-15(2-4-16)30-22(33)13-5-17(14-7-27-11-28-8-14)21-18(6-13)29-12-31(21)19-9-34-10-20(19)32/h1-8,11-12,19-20,32H,9-10H2,(H,30,33) DVGOZIUUSLOKKO-UHFFFAOYSA-N 477733 US10889571, Example 77::US20240101536, Example 77::US12240835, Example 77::US12454524, Example 77 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.710 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477733 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477733&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508260 442137347 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391760 O[C@H]1COC[C@H]1n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-16-3-1-15(2-4-16)30-22(33)13-5-17(14-7-27-11-28-8-14)21-18(6-13)29-12-31(21)19-9-34-10-20(19)32/h1-8,11-12,19-20,32H,9-10H2,(H,30,33) DVGOZIUUSLOKKO-UHFFFAOYSA-N 477734 US10889571, Example 78::US20240101536, Example 78::US12240835, Example 78::US12454524, Example 78 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.03 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477734 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477734&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507894 442137348 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391761 O[C@H]1COC[C@@H]1n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-16-3-1-15(2-4-16)30-22(33)13-5-17(14-7-27-11-28-8-14)21-18(6-13)29-12-31(21)19-9-34-10-20(19)32/h1-8,11-12,19-20,32H,9-10H2,(H,30,33) DVGOZIUUSLOKKO-UHFFFAOYSA-N 477735 US10889571, Example 79::US20240101536, Example 79::US12240835, Example 79::US12454524, Example 79 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.410 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477735 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477735&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507905 442137349 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391762 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3ccn[nH]3)c3n(cnc3c2)C2CC2)cc1 InChI=1S/C21H16ClF2N5O2/c22-21(23,24)31-15-5-1-13(2-6-15)27-20(30)12-9-16(17-7-8-26-28-17)19-18(10-12)25-11-29(19)14-3-4-14/h1-2,5-11,14H,3-4H2,(H,26,28)(H,27,30) FLYFAPGRTMGCTK-UHFFFAOYSA-N 477736 US10889571, Example 80::US20240101536, Example 80::US12240835, Example 80::US12454524, Example 80 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.310 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477736 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477736&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509047 442137350 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391763 Fc1cncc(c1)-c1cc(cc2ncn(C3CC3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H16ClF3N4O2/c24-23(26,27)33-18-5-1-16(2-6-18)30-22(32)13-8-19(14-7-15(25)11-28-10-14)21-20(9-13)29-12-31(21)17-3-4-17/h1-2,5-12,17H,3-4H2,(H,30,32) YVPSTQXKNDRZKC-UHFFFAOYSA-N 477737 US10889571, Example 81::US20240101536, Example 81::US12240835, Example 81::US12454524, Example 81 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.400 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477737 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477737&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507810 442137351 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391764 COc1ncc(cn1)-c1cc(cc2ncn(C3CC3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O3/c1-33-22-27-10-14(11-28-22)18-8-13(9-19-20(18)31(12-29-19)16-4-5-16)21(32)30-15-2-6-17(7-3-15)34-23(24,25)26/h2-3,6-12,16H,4-5H2,1H3,(H,30,32) GHROTMCCLXBVTK-UHFFFAOYSA-N 477738 US10889571, Example 82::US20240101536, Example 82::US12240835, Example 82::US12454524, Example 82 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.520 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477738 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477738&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507816 442137352 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391765 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)C2CC(F)(F)C2)cc1 InChI=1S/C23H16ClF4N5O2/c24-23(27,28)35-17-3-1-15(2-4-17)32-21(34)13-5-18(14-9-29-11-30-10-14)20-19(6-13)31-12-33(20)16-7-22(25,26)8-16/h1-6,9-12,16H,7-8H2,(H,32,34) ZDESOHKIMJDQFC-UHFFFAOYSA-N 477739 US10889571, Example 83::US20240101536, Example 83::US12240835, Example 83::US12454524, Example 83 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.400 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477739 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477739&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507897 442137353 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391766 O[C@H]1C[C@@H](C1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r,wU:3.5,wD:1.0,(9.78,-.76,;8.29,-1.16,;6.96,-.39,;6.19,-1.72,;7.52,-2.49,;4.7,-2.12,;4.07,-3.53,;2.54,-3.37,;2.22,-1.86,;.89,-1.09,;.89,.45,;2.22,1.22,;3.56,.45,;4.89,1.22,;6.22,.45,;7.56,1.22,;7.56,2.76,;6.22,3.53,;4.89,2.76,;3.56,-1.09,;-.44,1.22,;-.44,2.76,;-1.78,.45,;-3.11,1.22,;-4.45,.45,;-5.78,1.22,;-5.78,2.76,;-7.11,3.53,;-8.45,2.76,;-9.78,3.53,;-8.45,1.22,;-9.78,1.99,;-4.45,3.53,;-3.11,2.76,)| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-15(2-4-18)30-22(33)13-5-19(14-9-27-11-28-10-14)21-20(6-13)29-12-31(21)16-7-17(32)8-16/h1-6,9-12,16-17,32H,7-8H2,(H,30,33) DRLGQKRSNKZMSD-UHFFFAOYSA-N 477740 US10889571, Example 84::US20240101536, Example 84::US12240835, Example 84::US12454524, Example 84 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.570 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477740&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146458588 442137354 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391767 CC(C)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H18ClF2N5O2/c1-12(2)29-11-25-18-10-13(9-16(19(18)29)17-7-8-26-28-17)20(30)27-14-3-5-15(6-4-14)31-21(22,23)24/h3-12H,1-2H3,(H,26,28)(H,27,30) HTSZVWQNEAHBGD-UHFFFAOYSA-N 477741 US10889571, Example 85::US20240101536, Example 85::US12240835, Example 85::US12454524, Example 85 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.520 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477741 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477741&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507805 442137355 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391768 CC(C)n1cnc2cc(cc(-c3cncc(F)c3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF3N4O2/c1-13(2)31-12-29-20-9-14(8-19(21(20)31)15-7-16(25)11-28-10-15)22(32)30-17-3-5-18(6-4-17)33-23(24,26)27/h3-13H,1-2H3,(H,30,32) HXDUHXYQUKMWGT-UHFFFAOYSA-N 477742 US10889571, Example 86::US20240101536, Example 86::US12240835, Example 86::US12454524, Example 86 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.510 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477742&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508268 442137356 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391769 C[C@H](C1CC1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C24H20ClF2N5O2/c1-14(15-2-3-15)32-13-30-21-9-16(8-20(22(21)32)17-10-28-12-29-11-17)23(33)31-18-4-6-19(7-5-18)34-24(25,26)27/h4-15H,2-3H2,1H3,(H,31,33) AKQQEJPWRQCYSX-UHFFFAOYSA-N 477743 US10889571, Example 87::US20240101536, Example 87::US12240835, Example 87::US12454524, Example 87 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.440 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477743&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507820 442137357 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391770 C[C@@H](C1CC1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C24H20ClF2N5O2/c1-14(15-2-3-15)32-13-30-21-9-16(8-20(22(21)32)17-10-28-12-29-11-17)23(33)31-18-4-6-19(7-5-18)34-24(25,26)27/h4-15H,2-3H2,1H3,(H,31,33) AKQQEJPWRQCYSX-UHFFFAOYSA-N 477744 US10889571, Example 88::US20240101536, Example 88::US12240835, Example 88::US12454524, Example 88 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.620 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477744&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508269 442137358 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391771 COc1ncc(cn1)-c1cc(cc2ncn(C(C)C)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O3/c1-13(2)31-12-29-19-9-14(8-18(20(19)31)15-10-27-22(33-3)28-11-15)21(32)30-16-4-6-17(7-5-16)34-23(24,25)26/h4-13H,1-3H3,(H,30,32) BTEQUAFDCROZKE-UHFFFAOYSA-N 477745 US10889571, Example 89::US20240101536, Example 89::US12240835, Example 89::US12454524, Example 89 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.610 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477745&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507824 442137359 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391772 C[C@H](CO)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H18ClF2N5O3/c1-12(10-30)29-11-25-18-9-13(8-16(19(18)29)17-6-7-26-28-17)20(31)27-14-2-4-15(5-3-14)32-21(22,23)24/h2-9,11-12,30H,10H2,1H3,(H,26,28)(H,27,31) TUKCOCCMXNPSGU-UHFFFAOYSA-N 477746 US10889571, Example 90::US20240101536, Example 90::US12240835, Example 90::US12454524, Example 90 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.320 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477746&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507903 442137360 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391773 CC(C)(C)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O2/c1-22(2,3)31-13-29-19-9-14(8-18(20(19)31)15-10-27-12-28-11-15)21(32)30-16-4-6-17(7-5-16)33-23(24,25)26/h4-13H,1-3H3,(H,30,32) OPRSQUUWPZTWAQ-UHFFFAOYSA-N 477747 US10889571, Example 91::US20240101536, Example 91::US12240835, Example 91::US12454524, Example 91 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.500 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477747&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508272 442137361 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391774 FC(F)Cn1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H14ClF4N5O2/c22-21(25,26)33-15-3-1-14(2-4-15)30-20(32)12-5-16(13-7-27-10-28-8-13)19-17(6-12)29-11-31(19)9-18(23)24/h1-8,10-11,18H,9H2,(H,30,32) YGROTECFTJMFBU-UHFFFAOYSA-N 477748 US10889571, Example 92::US20240101536, Example 92::US12240835, Example 92::US12454524, Example 92 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.500 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477748&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509059 442137362 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391775 OCC1(CC1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-17-3-1-16(2-4-17)30-21(33)14-7-18(15-9-27-12-28-10-15)20-19(8-14)29-13-31(20)22(11-32)5-6-22/h1-4,7-10,12-13,32H,5-6,11H2,(H,30,33) YCKLWWIKAONNMI-UHFFFAOYSA-N 477749 US10889571, Example 93::US20240101536, Example 93::US12240835, Example 93::US12454524, Example 93 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.520 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477749&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508270 442137363 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391776 CC1(CC1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O2/c1-22(6-7-22)31-13-29-19-9-14(8-18(20(19)31)15-10-27-12-28-11-15)21(32)30-16-2-4-17(5-3-16)33-23(24,25)26/h2-5,8-13H,6-7H2,1H3,(H,30,32) OXMIVXSMFRCEQO-UHFFFAOYSA-N 477750 US10889571, Example 94::US20240101536, Example 94::US12240835, Example 94::US12454524, Example 94 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.520 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477750&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507813 442137364 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391777 C[C@@H](CO)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H18ClF2N5O3/c1-12(10-30)29-11-25-18-9-13(8-16(19(18)29)17-6-7-26-28-17)20(31)27-14-2-4-15(5-3-14)32-21(22,23)24/h2-9,11-12,30H,10H2,1H3,(H,26,28)(H,27,31) TUKCOCCMXNPSGU-UHFFFAOYSA-N 477751 US10889571, Example 95::US20240101536, Example 95::US12240835, Example 95::US12454524, Example 95 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.330 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477751&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508278 442137365 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391778 C[C@@H](C(F)F)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF4N5O2/c1-12(20(24)25)32-11-30-18-7-13(6-17(19(18)32)14-8-28-10-29-9-14)21(33)31-15-2-4-16(5-3-15)34-22(23,26)27/h2-12,20H,1H3,(H,31,33) BMYBZYNFHSITMK-UHFFFAOYSA-N 477752 US10889571, Example 96::US20240101536, Example 96::US12240835, Example 96::US12454524, Example 96 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.470 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477752&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507839 442137366 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391779 CC(C)n1cnc2cc(cc(-c3cncs3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H17ClF2N4O2S/c1-12(2)28-10-26-17-8-13(7-16(19(17)28)18-9-25-11-31-18)20(29)27-14-3-5-15(6-4-14)30-21(22,23)24/h3-12H,1-2H3,(H,27,29) NZJZWLULKHAADE-UHFFFAOYSA-N 477753 US10889571, Example 97::US20240101536, Example 97::US12240835, Example 97::US12454524, Example 97 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.590 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477753&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507838 442137367 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391780 C[C@H](C(F)F)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF4N5O2/c1-12(20(24)25)32-11-30-18-7-13(6-17(19(18)32)14-8-28-10-29-9-14)21(33)31-15-2-4-16(5-3-15)34-22(23,26)27/h2-12,20H,1H3,(H,31,33) BMYBZYNFHSITMK-UHFFFAOYSA-N 477754 US10889571, Example 98::US20240101536, Example 98::US12240835, Example 98::US12454524, Example 98 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.420 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477754&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507818 442137368 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391781 C[C@H](O)Cn1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-13(31)10-30-12-28-19-7-14(6-18(20(19)30)15-8-26-11-27-9-15)21(32)29-16-2-4-17(5-3-16)33-22(23,24)25/h2-9,11-13,31H,10H2,1H3,(H,29,32) WVCWFTPGMWAZDE-UHFFFAOYSA-N 477755 US10889571, Example 99::US20240101536, Example 99::US12240835, Example 99::US12454524, Example 99 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.410 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477755&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507827 442137369 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391782 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(CC4COC4)cnc3c2)cc1 InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-17(2-4-18)30-22(32)15-5-19(16-7-27-12-28-8-16)21-20(6-15)29-13-31(21)9-14-10-33-11-14/h1-8,12-14H,9-11H2,(H,30,32) ZNTLAUBFQCFUFC-UHFFFAOYSA-N 477756 US10889571, Example 100::US20240101536, Example 100::US12240835, Example 100::US12454524, Example 100 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.460 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477756&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507909 442137370 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391783 C[C@@H](O)Cn1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-13(31)10-30-12-28-19-7-14(6-18(20(19)30)15-8-26-11-27-9-15)21(32)29-16-2-4-17(5-3-16)33-22(23,24)25/h2-9,11-13,31H,10H2,1H3,(H,29,32) WVCWFTPGMWAZDE-UHFFFAOYSA-N 477757 US10889571, Example 101::US20240101536, Example 101::US12240835, Example 101::US12454524, Example 101 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.630 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477757&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507798 442137371 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391784 C[C@@H](CC#N)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H17ClF2N6O2/c1-14(6-7-27)32-13-30-20-9-15(8-19(21(20)32)16-10-28-12-29-11-16)22(33)31-17-2-4-18(5-3-17)34-23(24,25)26/h2-5,8-14H,6H2,1H3,(H,31,33) GTCGKSKFLJXACX-UHFFFAOYSA-N 477758 US10889571, Example 102::US20240101536, Example 102::US12240835, Example 102::US12454524, Example 102 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.610 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477758&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507802 442137372 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391785 C[C@H](CC#N)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H17ClF2N6O2/c1-14(6-7-27)32-13-30-20-9-15(8-19(21(20)32)16-10-28-12-29-11-16)22(33)31-17-2-4-18(5-3-17)34-23(24,25)26/h2-5,8-14H,6H2,1H3,(H,31,33) GTCGKSKFLJXACX-UHFFFAOYSA-N 477759 US10889571, Example 103::US20240101536, Example 103::US12240835, Example 103::US12454524, Example 103 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.460 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477759&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509062 442137373 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391786 CC(C1COC1)n1cnc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C24H20ClF2N5O3/c1-14(17-10-34-11-17)32-13-30-21-7-15(6-20(22(21)32)16-8-28-12-29-9-16)23(33)31-18-2-4-19(5-3-18)35-24(25,26)27/h2-9,12-14,17H,10-11H2,1H3,(H,31,33) KYEFERFLJVHJMW-UHFFFAOYSA-N 477760 US10889571, Example 104::US20240101536, Example 104::US12240835, Example 104::US12454524, Example 104 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.710 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477760&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507822 442137374 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391787 C[C@@H](C(F)F)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H16ClF4N5O2/c1-11(19(23)24)31-10-27-17-9-12(8-15(18(17)31)16-6-7-28-30-16)20(32)29-13-2-4-14(5-3-13)33-21(22,25)26/h2-11,19H,1H3,(H,28,30)(H,29,32) JHUOFPIRKKLGOG-UHFFFAOYSA-N 477761 US10889571, Example 105::US20240101536, Example 105::US12240835, Example 105::US12454524, Example 105 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.860 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477761&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507907 442137375 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391788 C[C@H](C(F)F)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H16ClF4N5O2/c1-11(19(23)24)31-10-27-17-9-12(8-15(18(17)31)16-6-7-28-30-16)20(32)29-13-2-4-14(5-3-13)33-21(22,25)26/h2-11,19H,1H3,(H,28,30)(H,29,32) JHUOFPIRKKLGOG-UHFFFAOYSA-N 477762 US10889571, Example 106::US20240101536, Example 106::US12240835, Example 106::US12454524, Example 106 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.290 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477762&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509057 442137376 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391789 CC(C)c1nc2c(cc(cc2n1C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)-c1cncnc1 InChI=1S/C23H20ClF2N5O2/c1-13(2)21-30-20-18(15-10-27-12-28-11-15)8-14(9-19(20)31(21)3)22(32)29-16-4-6-17(7-5-16)33-23(24,25)26/h4-13H,1-3H3,(H,29,32) CJHPEPRBOBRGSE-UHFFFAOYSA-N 477763 US10889571, Example 107::US20240101536, Example 107::US12240835, Example 107::US12454524, Example 107 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.770 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477763&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508271 442137377 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391790 Cc1nc2c(cc(cc2n1C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)-c1cncc(F)c1 InChI=1S/C22H16ClF3N4O2/c1-12-28-20-18(14-7-15(24)11-27-10-14)8-13(9-19(20)30(12)2)21(31)29-16-3-5-17(6-4-16)32-22(23,25)26/h3-11H,1-2H3,(H,29,31) AXALNAAWYDIGAU-UHFFFAOYSA-N 477764 US10889571, Example 108::US20240101536, Example 108::US12240835, Example 108::US12454524, Example 108 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.730 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477764 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477764&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507908 442137378 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391791 Cc1nc2c(cc(cc2n1C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)-c1ccn[nH]1 InChI=1S/C20H16ClF2N5O2/c1-11-25-18-15(16-7-8-24-27-16)9-12(10-17(18)28(11)2)19(29)26-13-3-5-14(6-4-13)30-20(21,22)23/h3-10H,1-2H3,(H,24,27)(H,26,29) OVJNAMCAMRZYJR-UHFFFAOYSA-N 477765 US10889571, Example 109::US12454524, Example 109 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.74 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477765 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477765&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 147398269 442137379 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391792 C[C@H](CO)n1c(C)nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O3/c1-13(11-32)31-14(2)29-20-8-15(7-19(21(20)31)16-9-27-12-28-10-16)22(33)30-17-3-5-18(6-4-17)34-23(24,25)26/h3-10,12-13,32H,11H2,1-2H3,(H,30,33) YOENPNSBFWVWDI-UHFFFAOYSA-N 477766 US10889571, Example 110::US20240101536, Example 110::US12240835, Example 110::US12454524, Example 110 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.510 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477766 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477766&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509064 442137380 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391793 CC(C)n1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C23H18ClF4N5O2/c1-12(2)33-19-17(14-9-29-11-30-10-14)7-13(8-18(19)32-21(33)20(25)26)22(34)31-15-3-5-16(6-4-15)35-23(24,27)28/h3-12,20H,1-2H3,(H,31,34) GIFKTWWSTQONCU-UHFFFAOYSA-N 477767 US10889571, Example 111::US20240101536, Example 111::US12240835, Example 111::US12454524, Example 111 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.600 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477767 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477767&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507844 442137381 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391794 Cc1nc2cc(cc(-c3cncnc3)c2n1C1CC1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H18ClF2N5O2/c1-13-29-20-9-14(22(32)30-16-2-6-18(7-3-16)33-23(24,25)26)8-19(15-10-27-12-28-11-15)21(20)31(13)17-4-5-17/h2-3,6-12,17H,4-5H2,1H3,(H,30,32) ZMSPINSEWYFRIT-UHFFFAOYSA-N 477768 US10889571, Example 112::US20240101536, Example 112::US12240835, Example 112::US12454524, Example 112 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.300 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477768&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507815 442137382 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391795 CC(C)n1c(C)nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C23H20ClF2N5O2/c1-13(2)31-14(3)29-20-9-15(8-19(21(20)31)16-10-27-12-28-11-16)22(32)30-17-4-6-18(7-5-17)33-23(24,25)26/h4-13H,1-3H3,(H,30,32) HYBJFDGUGJGKSQ-UHFFFAOYSA-N 477769 US10889571, Example 113::US20240101536, Example 113::US12240835, Example 113::US12454524, Example 113 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.400 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477769&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507831 442137383 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391796 CC(C)n1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C1CCOCC1 InChI=1S/C27H26ClF2N5O3/c1-16(2)35-24-22(19-13-31-15-32-14-19)11-18(12-23(24)34-25(35)17-7-9-37-10-8-17)26(36)33-20-3-5-21(6-4-20)38-27(28,29)30/h3-6,11-17H,7-10H2,1-2H3,(H,33,36) UKAUYZXLBZKMGN-UHFFFAOYSA-N 477770 US10889571, Example 114::US20240101536, Example 114::US12240835, Example 114::US12454524, Example 114 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.250 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477770&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507904 442137384 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391797 CC(C)n1c(nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C22H18ClF4N5O2/c1-11(2)32-18-15(16-7-8-28-31-16)9-12(10-17(18)30-20(32)19(24)25)21(33)29-13-3-5-14(6-4-13)34-22(23,26)27/h3-11,19H,1-2H3,(H,28,31)(H,29,33) ZPKMLWMQOLVASB-UHFFFAOYSA-N 477771 US10889571, Example 115::US20240101536, Example 115::US12240835, Example 115::US12454524, Example 115 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.540 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477771 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477771&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509065 442137385 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391798 Cn1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C1CC1 InChI=1S/C23H18ClF2N5O2/c1-31-20-18(15-10-27-12-28-11-15)8-14(9-19(20)30-21(31)13-2-3-13)22(32)29-16-4-6-17(7-5-16)33-23(24,25)26/h4-13H,2-3H2,1H3,(H,29,32) DWJMLTHBHYSIHX-UHFFFAOYSA-N 477772 US10889571, Example 116::US20240101536, Example 116::US12240835, Example 116::US12454524, Example 116 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.460 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477772&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508277 442137386 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391799 Cn1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(C)(C)O InChI=1S/C23H20ClF2N5O3/c1-22(2,33)21-30-18-9-13(8-17(19(18)31(21)3)14-10-27-12-28-11-14)20(32)29-15-4-6-16(7-5-15)34-23(24,25)26/h4-12,33H,1-3H3,(H,29,32) PXBXXGMXVUJZDN-UHFFFAOYSA-N 477773 US10889571, Example 117::US20240101536, Example 117::US12240835, Example 117::US12454524, Example 117 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.430 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477773&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507906 442137387 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391800 Cn1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C21H14ClF4N5O2/c1-31-17-15(12-8-27-10-28-9-12)6-11(7-16(17)30-19(31)18(23)24)20(32)29-13-2-4-14(5-3-13)33-21(22,25)26/h2-10,18H,1H3,(H,29,32) KSFQJNCHWONGSD-UHFFFAOYSA-N 477774 US10889571, Example 118::US20240101536, Example 118::US12240835, Example 118::US12454524, Example 118 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.340 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477774 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477774&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508276 442137388 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391801 Cn1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C1CCC1 InChI=1S/C24H20ClF2N5O2/c1-32-21-19(16-11-28-13-29-12-16)9-15(10-20(21)31-22(32)14-3-2-4-14)23(33)30-17-5-7-18(8-6-17)34-24(25,26)27/h5-14H,2-4H2,1H3,(H,30,33) CSZODSPLFARJCV-UHFFFAOYSA-N 477775 US10889571, Example 119::US20240101536, Example 119::US12240835, Example 119::US12454524, Example 119 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477775 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477775&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507825 442137389 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391802 Cn1c(CO)nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H16ClF2N5O3/c1-29-18(10-30)28-17-7-12(6-16(19(17)29)13-8-25-11-26-9-13)20(31)27-14-2-4-15(5-3-14)32-21(22,23)24/h2-9,11,30H,10H2,1H3,(H,27,31) HCFKYXQMFYVRMI-UHFFFAOYSA-N 477776 US10889571, Example 120::US20240101536, Example 120::US12240835, Example 120::US12454524, Example 120 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477776&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507833 442137390 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391803 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3ccn[nH]3)c3n4CCOCc4nc3c2)cc1 InChI=1S/C21H16ClF2N5O3/c22-21(23,24)32-14-3-1-13(2-4-14)26-20(30)12-9-15(16-5-6-25-28-16)19-17(10-12)27-18-11-31-8-7-29(18)19/h1-6,9-10H,7-8,11H2,(H,25,28)(H,26,30) RMMOCHXQZMOZLE-UHFFFAOYSA-N 477777 US10889571, Example 122::US20240101536, Example 122::US12240835, Example 122::US12454524, Example 122 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.420 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477777&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509060 442137391 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391804 C[C@@H]1Cn2c(CO1)nc1cc(cc(-c3cncnc3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-10-31-20(11-33-13)30-19-7-14(6-18(21(19)31)15-8-27-12-28-9-15)22(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-9,12-13H,10-11H2,1H3,(H,29,32) HKAMGRFXSYYUMP-UHFFFAOYSA-N 477778 US10889571, Example 123::US20240101536, Example 123::US12240835, Example 123::US12454524, Example 123 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.580 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477778&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507913 442137392 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391805 C[C@H]1Cn2c(CO1)nc1cc(cc(-c3cncnc3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-10-31-20(11-33-13)30-19-7-14(6-18(21(19)31)15-8-27-12-28-9-15)22(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-9,12-13H,10-11H2,1H3,(H,29,32) HKAMGRFXSYYUMP-UHFFFAOYSA-N 477779 US10889571, Example 124::US20240101536, Example 124::US12240835, Example 124::US12454524, Example 124 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.830 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477779&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507898 442137393 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391806 C[C@H]1COCc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-10-33-11-20-30-19-7-14(6-18(21(19)31(13)20)15-8-27-12-28-9-15)22(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-9,12-13H,10-11H2,1H3,(H,29,32) ZIFYQYNXVHYSIF-UHFFFAOYSA-N 477780 US10889571, Example 125::US20240101536, Example 125::US12240835, Example 125::US12454524, Example 125 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.35 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477780&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507836 442137394 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391807 C[C@@H]1COCc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-10-33-11-20-30-19-7-14(6-18(21(19)31(13)20)15-8-27-12-28-9-15)22(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-9,12-13H,10-11H2,1H3,(H,29,32) ZIFYQYNXVHYSIF-UHFFFAOYSA-N 477781 US10889571, Example 126::US20240101536, Example 126::US12240835, Example 126::US12454524, Example 126 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.250 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477781&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507901 442137395 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391808 COc1nc2cc(cc(-c3ccn[nH]3)c2n1C(C)C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H20ClF2N5O3/c1-12(2)30-19-16(17-8-9-26-29-17)10-13(11-18(19)28-21(30)32-3)20(31)27-14-4-6-15(7-5-14)33-22(23,24)25/h4-12H,1-3H3,(H,26,29)(H,27,31) XXDFSDVGHKLZPE-UHFFFAOYSA-N 477782 US10889571, Example 127::US20240101536, Example 127::US12240835, Example 127::US12454524, Example 127 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477782 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477782&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508275 442137396 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391809 CCOc1nc2cc(cc(-c3cncnc3)c2n1C(C)C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C24H22ClF2N5O3/c1-4-34-23-31-20-10-15(22(33)30-17-5-7-18(8-6-17)35-24(25,26)27)9-19(16-11-28-13-29-12-16)21(20)32(23)14(2)3/h5-14H,4H2,1-3H3,(H,30,33) XMGLLANMUNAKQY-UHFFFAOYSA-N 477783 US10889571, Example 128::US20240101536, Example 128::US12240835, Example 128::US12454524, Example 128 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477783&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507812 442137397 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391810 FC(F)(Cl)Oc1ccc(NC(=O)c2cc(-c3cncnc3)c3n(cnc3c2)[C@H]2CNC(=O)C2)cc1 |r| InChI=1S/C23H17ClF2N6O3/c24-23(25,26)35-17-3-1-15(2-4-17)31-22(34)13-5-18(14-8-27-11-28-9-14)21-19(6-13)30-12-32(21)16-7-20(33)29-10-16/h1-6,8-9,11-12,16H,7,10H2,(H,29,33)(H,31,34) CZOIQQDHLUKMSV-UHFFFAOYSA-N 477784 US10889571, Example 129::US20240101536, Example 129::US12240835, Example 129::US12454524, Example 129 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.07 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477784&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507841 442137398 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391811 FC(F)c1nc2cc(cc(-c3ccn[nH]3)c2n1C1CC1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H16ClF4N5O2/c23-22(26,27)34-14-5-1-12(2-6-14)29-21(33)11-9-15(16-7-8-28-31-16)18-17(10-11)30-20(19(24)25)32(18)13-3-4-13/h1-2,5-10,13,19H,3-4H2,(H,28,31)(H,29,33) KIWQPOXFRCDVFJ-UHFFFAOYSA-N 477785 US10889571, Example 130::US20240101536, Example 130::US12240835, Example 130::US12454524, Example 130 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.450 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477785&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507912 442137399 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391812 C[C@H](CF)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H17ClF3N5O2/c1-12(10-23)30-11-26-18-9-13(8-16(19(18)30)17-6-7-27-29-17)20(31)28-14-2-4-15(5-3-14)32-21(22,24)25/h2-9,11-12H,10H2,1H3,(H,27,29)(H,28,31) ATOBCMYHXGQAAO-UHFFFAOYSA-N 477786 US10889571, Example 131::US20240101536, Example 131::US12240835, Example 131::US12454524, Example 131 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477786&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508280 442137400 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391813 C[C@H](CF)n1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F |r| InChI=1S/C23H17ClF5N5O2/c1-12(8-25)34-19-17(14-9-30-11-31-10-14)6-13(7-18(19)33-21(34)20(26)27)22(35)32-15-2-4-16(5-3-15)36-23(24,28)29/h2-7,9-12,20H,8H2,1H3,(H,32,35) NTSZYMZKJNINOT-UHFFFAOYSA-N 477787 US10889571, Example 132::US20240101536, Example 132::US12240835, Example 132::US12454524, Example 132 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.540 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477787&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507914 442137401 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391814 C[C@@H]1COCc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-12-10-32-11-19-28-18-9-13(8-16(20(18)30(12)19)17-6-7-26-29-17)21(31)27-14-2-4-15(5-3-14)33-22(23,24)25/h2-9,12H,10-11H2,1H3,(H,26,29)(H,27,31) HWFMQRFURPEXJJ-UHFFFAOYSA-N 477788 US10889571, Example 133::US20240101536, Example 133::US12240835, Example 133::US12454524, Example 133 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.310 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477788&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507917 442137402 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391815 CC(C)n1cnc2cc(cc(-c3n[nH]cc3O)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H18ClF2N5O3/c1-11(2)29-10-25-16-8-12(7-15(19(16)29)18-17(30)9-26-28-18)20(31)27-13-3-5-14(6-4-13)32-21(22,23)24/h3-11,30H,1-2H3,(H,26,28)(H,27,31) MSPMZXZZMLFXBH-UHFFFAOYSA-N 477789 US10889571, Example 134::US20240101536, Example 134::US12240835, Example 134::US12454524, Example 134 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.650 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477789&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507916 442137403 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391816 C[C@@H](CF)n1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F |r| InChI=1S/C23H17ClF5N5O2/c1-12(8-25)34-19-17(14-9-30-11-31-10-14)6-13(7-18(19)33-21(34)20(26)27)22(35)32-15-2-4-16(5-3-15)36-23(24,28)29/h2-7,9-12,20H,8H2,1H3,(H,32,35) NTSZYMZKJNINOT-UHFFFAOYSA-N 477790 US10889571, Example 135::US20240101536, Example 135::US12240835, Example 135::US12454524, Example 135 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477790&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507837 442137404 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391817 C[C@@H](CF)n1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H17ClF3N5O2/c1-12(10-23)30-11-26-18-9-13(8-16(19(18)30)17-6-7-27-29-17)20(31)28-14-2-4-15(5-3-14)32-21(22,24)25/h2-9,11-12H,10H2,1H3,(H,27,29)(H,28,31) ATOBCMYHXGQAAO-UHFFFAOYSA-N 477791 US10889571, Example 137::US20240101536, Example 137::US12240835, Example 137::US12454524, Example 137 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.560 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477791&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508279 442137405 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391818 C[C@@H](CF)n1c(nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F |r| InChI=1S/C22H17ClF5N5O2/c1-11(10-24)33-18-15(16-6-7-29-32-16)8-12(9-17(18)31-20(33)19(25)26)21(34)30-13-2-4-14(5-3-13)35-22(23,27)28/h2-9,11,19H,10H2,1H3,(H,29,32)(H,30,34) FQWJQIWICAZVNL-UHFFFAOYSA-N 477792 US10889571, Example 138::US20240101536, Example 138::US12240835, Example 138::US12454524, Example 138 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.520 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477792&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507853 442137406 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391819 CC(C)n1cnc2cc(cc(-c3ccnn3C)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H20ClF2N5O2/c1-13(2)30-12-26-18-11-14(10-17(20(18)30)19-8-9-27-29(19)3)21(31)28-15-4-6-16(7-5-15)32-22(23,24)25/h4-13H,1-3H3,(H,28,31) JSRQXRDCECTONI-UHFFFAOYSA-N 477793 US10889571, Example 139::US20240101536, Example 139::US12240835, Example 139::US12454524, Example 139 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 2.49 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477793&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507858 442137407 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391820 CC(C)n1cnc2cc(cc(-c3ccn(C)n3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H20ClF2N5O2/c1-13(2)30-12-26-19-11-14(10-17(20(19)30)18-8-9-29(3)28-18)21(31)27-15-4-6-16(7-5-15)32-22(23,24)25/h4-13H,1-3H3,(H,27,31) IGELPTLZEWSDSK-UHFFFAOYSA-N 477794 US10889571, Example 140::US20240101536, Example 140::US12240835, Example 140::US12454524, Example 140 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.26 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477794&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507918 442137408 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391821 C[C@@H]1CCOc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-12-7-9-32-21-28-18-11-13(10-16(19(18)30(12)21)17-6-8-26-29-17)20(31)27-14-2-4-15(5-3-14)33-22(23,24)25/h2-6,8,10-12H,7,9H2,1H3,(H,26,29)(H,27,31) QYPCRNHUDMNGDA-UHFFFAOYSA-N 477795 US10889571, Example 141::US20240101536, Example 141::US12240835, Example 141::US12454524, Example 141 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.340 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477795&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508282 442137409 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391822 C[C@@H]1CCOc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-6-7-33-22-30-19-9-14(8-18(20(19)31(13)22)15-10-27-12-28-11-15)21(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-5,8-13H,6-7H2,1H3,(H,29,32) VOWYIQCGNDZKAR-UHFFFAOYSA-N 477796 US10889571, Example 142::US20240101536, Example 142::US12240835, Example 142::US12454524, Example 142 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.300 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477796&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507828 442137410 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391823 CC(C)n1cnc2cc(cc(-c3cnsc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H17ClF2N4O2S/c1-12(2)28-11-25-18-8-13(7-17(19(18)28)14-9-26-31-10-14)20(29)27-15-3-5-16(6-4-15)30-21(22,23)24/h3-12H,1-2H3,(H,27,29) UQCAGYWXVAKZQS-UHFFFAOYSA-N 477797 US10889571, Example 143::US20240101536, Example 143::US12240835, Example 143::US12454524, Example 143 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477797&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507860 442137411 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391824 C[C@@H]1COCc2nc3cc(cc(-c4cnsc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O3S/c1-12-9-31-10-19-28-18-7-13(6-17(20(18)29(12)19)14-8-26-33-11-14)21(30)27-15-2-4-16(5-3-15)32-22(23,24)25/h2-8,11-12H,9-10H2,1H3,(H,27,30) HEYDMYGENZBNEP-UHFFFAOYSA-N 477798 US10889571, Example 144::US20240101536, Example 144::US12240835, Example 144::US12454524, Example 144 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.350 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477798&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508265 442137412 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391825 CC(C)n1cnc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O2/c1-13(2)30-12-26-19-11-14(10-17(20(19)30)18-4-3-9-27-29-18)21(31)28-15-5-7-16(8-6-15)32-22(23,24)25/h3-13H,1-2H3,(H,28,31) DYTGMPHXZKAEER-UHFFFAOYSA-N 477799 US10889571, Example 145::US20240101536, Example 145::US12240835, Example 145::US12454524, Example 145 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.570 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477799&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509055 442137413 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391826 C[C@@H]1COCc2nc3cc(cc(-c4cnn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H17ClF2N6O3/c1-11-9-32-10-18-27-16-7-12(6-15(19(16)30(11)18)17-8-25-29-28-17)20(31)26-13-2-4-14(5-3-13)33-21(22,23)24/h2-8,11H,9-10H2,1H3,(H,26,31)(H,25,28,29) JIOMKTUTWUHZJQ-UHFFFAOYSA-N 477800 US10889571, Example 146::US20240101536, Example 146::US12240835, Example 146::US12454524, Example 146 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.330 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477800&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508281 442137414 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391827 CC(C)n1c(nc2cc(cc(-c3cnsc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C22H17ClF4N4O2S/c1-11(2)31-18-16(13-9-28-34-10-13)7-12(8-17(18)30-20(31)19(24)25)21(32)29-14-3-5-15(6-4-14)33-22(23,26)27/h3-11,19H,1-2H3,(H,29,32) CUAKGWPJKKJQHH-UHFFFAOYSA-N 477801 US10889571, Example 147::US20240101536, Example 147::US12240835, Example 147::US12454524, Example 147 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.390 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477801&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507835 442137415 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391828 C[C@@H]1COCc2nc3cc(cc(-c4cscn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O3S/c1-12-8-31-9-19-28-17-7-13(6-16(20(17)29(12)19)18-10-33-11-26-18)21(30)27-14-2-4-15(5-3-14)32-22(23,24)25/h2-7,10-12H,8-9H2,1H3,(H,27,30) JXZPCAGEZOGPMK-UHFFFAOYSA-N 477802 US10889571, Example 148::US20240101536, Example 148::US12240835, Example 148::US12454524, Example 148 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.540 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477802&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508285 442137416 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391829 C[C@@H]1CCSc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O2S/c1-12-7-9-33-21-28-18-11-13(10-16(19(18)30(12)21)17-6-8-26-29-17)20(31)27-14-2-4-15(5-3-14)32-22(23,24)25/h2-6,8,10-12H,7,9H2,1H3,(H,26,29)(H,27,31) URWZBXPNOFMCST-UHFFFAOYSA-N 477803 US10889571, Example 149::US20240101536, Example 149::US12240835, Example 149::US12454524, Example 149 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477803&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507925 442137417 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391830 C[C@@H]1CCSc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O2S/c1-13-6-7-34-22-30-19-9-14(8-18(20(19)31(13)22)15-10-27-12-28-11-15)21(32)29-16-2-4-17(5-3-16)33-23(24,25)26/h2-5,8-13H,6-7H2,1H3,(H,29,32) YUQBVYMLIBOVAS-UHFFFAOYSA-N 477804 US10889571, Example 150::US20240101536, Example 150::US12240835, Example 150::US12454524, Example 150 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.360 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477804&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507829 442137418 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391831 CC(C)n1c(nc2cc(cc(-c3cscn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C22H17ClF4N4O2S/c1-11(2)31-18-15(17-9-34-10-28-17)7-12(8-16(18)30-20(31)19(24)25)21(32)29-13-3-5-14(6-4-13)33-22(23,26)27/h3-11,19H,1-2H3,(H,29,32) LTFVBNVRGUPWJI-UHFFFAOYSA-N 477805 US10889571, Example 151::US20240101536, Example 151::US12240835, Example 151::US12454524, Example 151 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.770 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477805&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508273 442137419 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391832 C[C@@H]1CSc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H16ClF2N5O2S/c1-11-10-32-20-27-17-9-12(8-15(18(17)29(11)20)16-6-7-25-28-16)19(30)26-13-2-4-14(5-3-13)31-21(22,23)24/h2-9,11H,10H2,1H3,(H,25,28)(H,26,30) CLUDREKWKCUKIF-UHFFFAOYSA-N 477806 US10889571, Example 152::US20240101536, Example 152::US12240835, Example 152::US12454524, Example 152 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.560 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477806&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507845 442137420 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391833 C[C@@H]1COCc2nc3cc(cc(-c4cncc(c4)C#N)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C25H18ClF2N5O3/c1-14-12-35-13-22-32-21-8-16(24(34)31-18-2-4-19(5-3-18)36-25(26,27)28)7-20(23(21)33(14)22)17-6-15(9-29)10-30-11-17/h2-8,10-11,14H,12-13H2,1H3,(H,31,34) KMQIAWGDSYNVJT-UHFFFAOYSA-N 477807 US10889571, Example 153::US20240101536, Example 153::US12240835, Example 153::US12454524, Example 153 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.280 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477807&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508287 442137421 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391834 C[C@@H]1CCOc2nc3cc(cc(-c4cnsc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O3S/c1-12-6-7-31-21-28-18-9-13(8-17(19(18)29(12)21)14-10-26-33-11-14)20(30)27-15-2-4-16(5-3-15)32-22(23,24)25/h2-5,8-12H,6-7H2,1H3,(H,27,30) FDAODMPZZXVQBF-UHFFFAOYSA-N 477808 US10889571, Example 154::US20240101536, Example 154::US12240835, Example 154::US12454524, Example 154 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.430 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477808&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507840 442137422 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391835 C[C@@H]1CCc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O2/c1-12-2-7-19-28-18-11-13(10-16(20(18)30(12)19)17-8-9-26-29-17)21(31)27-14-3-5-15(6-4-14)32-22(23,24)25/h3-6,8-12H,2,7H2,1H3,(H,26,29)(H,27,31) VOBQMANRYXYLOV-UHFFFAOYSA-N 477809 US10889571, Example 155::US20240101536, Example 155::US12240835, Example 155::US12454524, Example 155 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.970 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477809&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507846 442137423 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391836 C[C@@H]1COCc2nc3cc(cc(-c4ccnnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-11-33-12-20-30-19-9-15(8-18(21(19)31(13)20)14-6-7-27-28-10-14)22(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-10,13H,11-12H2,1H3,(H,29,32) YNQQWUGAUZWHGS-UHFFFAOYSA-N 477810 US10889571, Example 156::US20240101536, Example 156::US12240835, Example 156::US12454524, Example 156 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.350 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477810&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509068 442137424 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391837 C[C@@H]1CCOc2nc3cc(cc(-c4cscn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O3S/c1-12-6-7-31-21-28-17-9-13(8-16(19(17)29(12)21)18-10-33-11-26-18)20(30)27-14-2-4-15(5-3-14)32-22(23,24)25/h2-5,8-12H,6-7H2,1H3,(H,27,30) MHURZQOZVLWMLN-UHFFFAOYSA-N 477811 US10889571, Example 157::US20240101536, Example 157::US12240835, Example 157::US12454524, Example 157 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.350 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477811 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477811&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509051 442137425 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391838 C[C@@H]1CCOc2nc3cc(cc(-c4cncc(c4)C#N)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C25H18ClF2N5O3/c1-14-6-7-35-24-32-21-10-16(23(34)31-18-2-4-19(5-3-18)36-25(26,27)28)9-20(22(21)33(14)24)17-8-15(11-29)12-30-13-17/h2-5,8-10,12-14H,6-7H2,1H3,(H,31,34) MOONGUKWKFEHKA-UHFFFAOYSA-N 477812 US10889571, Example 158::US20240101536, Example 158::US12240835, Example 158::US12454524, Example 158 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.340 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477812&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507921 442137426 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391839 C[C@@H]1COCc2nc3cc(cc(-c4cncs4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O3S/c1-12-9-31-10-19-28-17-7-13(6-16(20(17)29(12)19)18-8-26-11-33-18)21(30)27-14-2-4-15(5-3-14)32-22(23,24)25/h2-8,11-12H,9-10H2,1H3,(H,27,30) RSQVCIYKJMMZDX-UHFFFAOYSA-N 477813 US10889571, Example 159::US20240101536, Example 159::US12240835, Example 159::US12454524, Example 159 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.280 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477813&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507847 442137427 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391840 C[C@@H]1COCc2nc3cc(cc(-c4cnoc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O4/c1-12-9-31-11-19-28-18-7-13(6-17(20(18)29(12)19)14-8-26-32-10-14)21(30)27-15-2-4-16(5-3-15)33-22(23,24)25/h2-8,10,12H,9,11H2,1H3,(H,27,30) CBYIRFSPAIUUNB-UHFFFAOYSA-N 477814 US10889571, Example 160::US20240101536, Example 160::US12240835, Example 160::US12454524, Example 160 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.520 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477814&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507871 442137428 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391841 C[C@@H]1COCc2nc3cc(cc(-c4nccs4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O3S/c1-12-10-31-11-18-28-17-9-13(8-16(19(17)29(12)18)21-26-6-7-33-21)20(30)27-14-2-4-15(5-3-14)32-22(23,24)25/h2-9,12H,10-11H2,1H3,(H,27,30) BGBFZLAGZAPIOQ-UHFFFAOYSA-N 477815 US10889571, Example 161::US20240101536, Example 161::US12240835, Example 161::US12454524, Example 161 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.550 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477815&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508290 442137429 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391842 C[C@@H]1COCc2nc3cc(cc(-c4csc(C)n4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H19ClF2N4O3S/c1-12-9-32-10-20-29-18-8-14(7-17(21(18)30(12)20)19-11-34-13(2)27-19)22(31)28-15-3-5-16(6-4-15)33-23(24,25)26/h3-8,11-12H,9-10H2,1-2H3,(H,28,31) LDLCFIHKUUOCHY-UHFFFAOYSA-N 477816 US10889571, Example 162::US20240101536, Example 162::US12240835, Example 162::US12454524, Example 162 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.730 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477816&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507923 442137430 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391843 C[C@@H]1COCc2nc3cc(cc(-c4csc(n4)C#N)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H16ClF2N5O3S/c1-12-9-33-10-19-29-17-7-13(6-16(21(17)31(12)19)18-11-35-20(8-27)30-18)22(32)28-14-2-4-15(5-3-14)34-23(24,25)26/h2-7,11-12H,9-10H2,1H3,(H,28,32) GLEATNQORVQDBF-UHFFFAOYSA-N 477817 US10889571, Example 163::US20240101536, Example 163::US12240835, Example 163::US12454524, Example 163 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.630 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477817&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507814 442137431 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391844 C[C@@H]1COCc2nc3cc(cc(-c4[nH]ncc4F)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF3N5O3/c1-11-9-33-10-18-29-17-7-12(6-15(20(17)31(11)18)19-16(24)8-27-30-19)21(32)28-13-2-4-14(5-3-13)34-22(23,25)26/h2-8,11H,9-10H2,1H3,(H,27,30)(H,28,32) BOFNGKITSMNBOI-UHFFFAOYSA-N 477818 US10889571, Example 164::US20240101536, Example 164::US12240835, Example 164::US12454524, Example 164 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.810 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477818&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507851 442137432 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391845 C[C@@H]1CCOc2nc3cc(cc(-c4[nH]ncc4F)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF3N5O3/c1-11-6-7-33-21-29-17-9-12(8-15(19(17)31(11)21)18-16(24)10-27-30-18)20(32)28-13-2-4-14(5-3-13)34-22(23,25)26/h2-5,8-11H,6-7H2,1H3,(H,27,30)(H,28,32) ZOZHHMYNTJGSGR-UHFFFAOYSA-N 477819 US10889571, Example 165::US20240101536, Example 165::US12240835, Example 165::US12454524, Example 165 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.380 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477819&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507848 442137433 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391846 C[C@@H]1COCc2nc3cc(cc(-c4[nH]ncc4C)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O3/c1-12-9-27-30-20(12)17-7-14(8-18-21(17)31-13(2)10-33-11-19(31)29-18)22(32)28-15-3-5-16(6-4-15)34-23(24,25)26/h3-9,13H,10-11H2,1-2H3,(H,27,30)(H,28,32) HTXGDIPOELGCGJ-UHFFFAOYSA-N 477820 US10889571, Example 166::US20240101536, Example 166::US12240835, Example 166::US12454524, Example 166 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.450 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477820&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509070 442137434 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391847 C[C@@H]1COCc2nc3cc(cc(-c4cccnn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-11-33-12-20-29-19-10-14(9-17(21(19)31(13)20)18-3-2-8-27-30-18)22(32)28-15-4-6-16(7-5-15)34-23(24,25)26/h2-10,13H,11-12H2,1H3,(H,28,32) VKGCIOSZJQKDKN-UHFFFAOYSA-N 477821 US10889571, Example 167::US20240101536, Example 167::US12240835, Example 167::US12454524, Example 167 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 2.51 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477821&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507910 442137435 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391848 OC[C@@H]1COCc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-17-3-1-15(2-4-17)29-22(33)13-5-18(14-7-27-12-28-8-14)21-19(6-13)30-20-11-34-10-16(9-32)31(20)21/h1-8,12,16,32H,9-11H2,(H,29,33) UDFFRXXPDSPBRE-UHFFFAOYSA-N 477822 US10889571, Example 168::US20240101536, Example 168::US12240835, Example 168::US12454524, Example 168 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.330 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477822&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508286 442137436 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391849 CC[C@@H]1COCc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O3/c1-2-15-11-33-12-20-29-19-10-13(9-17(21(19)31(15)20)18-7-8-27-30-18)22(32)28-14-3-5-16(6-4-14)34-23(24,25)26/h3-10,15H,2,11-12H2,1H3,(H,27,30)(H,28,32) RMWKSKZQCYBUBH-UHFFFAOYSA-N 477823 US10889571, Example 169::US20240101536, Example 169::US12240835, Example 169::US12454524, Example 169 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.530 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477823&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509073 442137437 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391850 CCn1cnc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C20H16ClF2N5O2/c1-2-28-11-24-17-10-12(9-15(18(17)28)16-7-8-25-27-16)19(29)26-13-3-5-14(6-4-13)30-20(21,22)23/h3-11H,2H2,1H3,(H,25,27)(H,26,29) DLZUPXGPCWUOQR-UHFFFAOYSA-N 477824 US10889571, Example 170::US20240101536, Example 170::US12240835, Example 170::US12454524, Example 170 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.490 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477824&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509069 442137438 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391851 C[C@@H]1COCc2nc3cc(cc(-c4[nH]ncc4C#N)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H17ClF2N6O3/c1-12-10-34-11-19-30-18-7-13(6-17(21(18)32(12)19)20-14(8-27)9-28-31-20)22(33)29-15-2-4-16(5-3-15)35-23(24,25)26/h2-7,9,12H,10-11H2,1H3,(H,28,31)(H,29,33) PFCPZACPVIQLFT-UHFFFAOYSA-N 477825 US10889571, Example 173::US20240101536, Example 173::US12454524, Example 173 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.760 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477825&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508283 442137439 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391852 C[C@@H]1COCc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)F)cc1 |r| InChI=1S/C23H18F3N5O3/c1-13-10-33-11-20-30-19-7-14(6-18(21(19)31(13)20)15-8-27-12-28-9-15)22(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-9,12-13H,10-11H2,1H3,(H,29,32) BJCMKRJHCVZHCV-UHFFFAOYSA-N 477826 US10889571, Example 174::US20240101536, Example 174 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.470 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477826 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477826&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509074 442137440 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391853 C[C@@H]1COCc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)F)cc1 |r| InChI=1S/C22H18F3N5O3/c1-12-10-32-11-19-28-18-9-13(8-16(20(18)30(12)19)17-6-7-26-29-17)21(31)27-14-2-4-15(5-3-14)33-22(23,24)25/h2-9,12H,10-11H2,1H3,(H,26,29)(H,27,31) PJHUCTXFNPTPHX-UHFFFAOYSA-N 477827 US10889571, Example 175::US20240101536, Example 175 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.460 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477827 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477827&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507834 442137441 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391854 C[C@@H]1CCOc2nc3cc(cc(-c4ccnnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-7-9-33-22-30-19-11-15(10-18(20(19)31(13)22)14-6-8-27-28-12-14)21(32)29-16-2-4-17(5-3-16)34-23(24,25)26/h2-6,8,10-13H,7,9H2,1H3,(H,29,32) JVBXPEBYOSISCS-UHFFFAOYSA-N 477828 US10889571, Example 176::US20240101536, Example 176::US12240835, Example 176::US12454524, Example 176 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.510 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477828 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477828&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507843 442137442 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391855 O[C@@H]1CCc2nc3cc(cc(-c4ccn[nH]4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c23-22(24,25)33-15-4-1-13(2-5-15)27-21(32)12-9-16(17-7-8-26-29-17)20-18(10-12)28-19-6-3-14(31)11-30(19)20/h1-2,4-5,7-10,14,31H,3,6,11H2,(H,26,29)(H,27,32) MGZSGMNMHTZJLY-UHFFFAOYSA-N 477829 US10889571, Example 177::US20240101536, Example 177::US12240835, Example 177::US12454524, Example 177 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.620 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477829 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477829&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507872 442137443 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391856 OC[C@@H]1COCc2nc3cc(cc(-c4ccnnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-17-3-1-15(2-4-17)29-22(33)14-7-18(13-5-6-27-28-9-13)21-19(8-14)30-20-12-34-11-16(10-32)31(20)21/h1-9,16,32H,10-12H2,(H,29,33) LZBSIOHAMWHJPZ-UHFFFAOYSA-N 477830 US10889571, Example 178::US20240101536, Example 178::US12240835, Example 178::US12454524, Example 178 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.700 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477830 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477830&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507832 442137444 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391857 C[C@@H]1COCc2nc3cc(cc(-c4ncco4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O4/c1-12-10-31-11-18-28-17-9-13(8-16(19(17)29(12)18)21-26-6-7-32-21)20(30)27-14-2-4-15(5-3-14)33-22(23,24)25/h2-9,12H,10-11H2,1H3,(H,27,30) QANKGXHIGMBTDH-UHFFFAOYSA-N 477831 US10889571, Example 179::US20240101536, Example 179::US12240835, Example 179::US12454524, Example 179 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.52 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477831 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477831&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507830 442137445 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391858 C[C@@H](O)c1nc2cc(cc(-c3ccn[nH]3)c2n1C(C)C)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H22ClF2N5O3/c1-12(2)31-20-17(18-8-9-27-30-18)10-14(11-19(20)29-21(31)13(3)32)22(33)28-15-4-6-16(7-5-15)34-23(24,25)26/h4-13,32H,1-3H3,(H,27,30)(H,28,33) ZGTQWBTZDSRSME-UHFFFAOYSA-N 477832 US10889571, Example 180::US20240101536, Example 180::US12240835, Example 180::US12454524, Example 180 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.13 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477832 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477832&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507861 442137446 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391859 O[C@H]1CCCn2c1nc1cc(cc(-c3ccn[nH]3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c23-22(24,25)33-14-5-3-13(4-6-14)27-21(32)12-10-15(16-7-8-26-29-16)19-17(11-12)28-20-18(31)2-1-9-30(19)20/h3-8,10-11,18,31H,1-2,9H2,(H,26,29)(H,27,32) RQGWLSGIZDXUSB-UHFFFAOYSA-N 477833 US10889571, Example 181::US20240101536, Example 181::US12240835, Example 181::US12454524, Example 181 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.760 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477833&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507926 442137447 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391860 C[C@@H]1COCc2nc3cc(cc(-c4cc(n[nH]4)C#N)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H17ClF2N6O3/c1-12-10-34-11-20-29-19-7-13(6-17(21(19)32(12)20)18-8-15(9-27)30-31-18)22(33)28-14-2-4-16(5-3-14)35-23(24,25)26/h2-8,12H,10-11H2,1H3,(H,28,33)(H,30,31) RJXZTJRDDBZECJ-UHFFFAOYSA-N 477834 US10889571, Example 182::US20240101536, Example 182::US12240835, Example 182::US12454524, Example 182 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.590 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477834 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477834&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507857 442137448 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391861 O[C@H]1CCc2nc3cc(cc(-c4ccn[nH]4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c23-22(24,25)33-15-4-1-13(2-5-15)27-21(32)12-9-16(17-7-8-26-29-17)20-18(10-12)28-19-6-3-14(31)11-30(19)20/h1-2,4-5,7-10,14,31H,3,6,11H2,(H,26,29)(H,27,32) MGZSGMNMHTZJLY-UHFFFAOYSA-N 477835 US10889571, Example 183::US20240101536, Example 183::US12240835, Example 183::US12454524, Example 183 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.380 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477835&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509071 442137449 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391862 CC(C)n1c(nc2cc(cc(-c3ccnnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C23H18ClF4N5O2/c1-12(2)33-19-17(13-7-8-29-30-11-13)9-14(10-18(19)32-21(33)20(25)26)22(34)31-15-3-5-16(6-4-15)35-23(24,27)28/h3-12,20H,1-2H3,(H,31,34) KUQIKXRRVQOSMR-UHFFFAOYSA-N 477836 US10889571, Example 184::US20240101536, Example 184::US12240835, Example 184::US12454524, Example 184 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.590 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477836 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477836&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507865 442137450 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391863 C[C@@H]1CCOc2nc3cc(cc(-c4cccnn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c1-13-8-10-33-22-29-19-12-14(11-17(20(19)31(13)22)18-3-2-9-27-30-18)21(32)28-15-4-6-16(7-5-15)34-23(24,25)26/h2-7,9,11-13H,8,10H2,1H3,(H,28,32) KVSNOBXGMVEAEN-UHFFFAOYSA-N 477837 US10889571, Example 185::US20240101536, Example 185::US12240835, Example 185::US12454524, Example 185 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.310 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477837 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477837&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507873 442137451 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391864 CCn1c(nc2cc(cc(-c3ccnnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C22H16ClF4N5O2/c1-2-32-18-16(12-7-8-28-29-11-12)9-13(10-17(18)31-20(32)19(24)25)21(33)30-14-3-5-15(6-4-14)34-22(23,26)27/h3-11,19H,2H2,1H3,(H,30,33) AOBUCIPCCRFBOZ-UHFFFAOYSA-N 477838 US10889571, Example 186::US20240101536, Example 186::US12240835, Example 186::US12454524, Example 186 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.450 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477838 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477838&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508289 442137452 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391865 CCn1c(nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@H](C)O |r| InChI=1S/C22H20ClF2N5O3/c1-3-30-19-16(17-8-9-26-29-17)10-13(11-18(19)28-20(30)12(2)31)21(32)27-14-4-6-15(7-5-14)33-22(23,24)25/h4-12,31H,3H2,1-2H3,(H,26,29)(H,27,32) ZSLCDSLWMLDQSO-UHFFFAOYSA-N 477839 US10889571, Example 187::US20240101536, Example 187 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.330 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477839 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477839&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508288 442137453 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391866 CCn1c(nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@@H](C)O |r| InChI=1S/C22H20ClF2N5O3/c1-3-30-19-16(17-8-9-26-29-17)10-13(11-18(19)28-20(30)12(2)31)21(32)27-14-4-6-15(7-5-14)33-22(23,24)25/h4-12,31H,3H2,1-2H3,(H,26,29)(H,27,32) ZSLCDSLWMLDQSO-UHFFFAOYSA-N 477840 US10889571, Example 188::US20240101536, Example 188::US12240835, Example 188::US12454524, Example 188 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477840 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477840&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508284 442137454 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391867 C[C@H](C(F)F)n1cnc2cc(cc(-c3ccnnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF4N5O2/c1-12(20(24)25)32-11-28-18-9-14(8-17(19(18)32)13-6-7-29-30-10-13)21(33)31-15-2-4-16(5-3-15)34-22(23,26)27/h2-12,20H,1H3,(H,31,33) DCRSWRXYHGUTFA-UHFFFAOYSA-N 477841 US10889571, Example 189::US20240101536, Example 189::US12240835, Example 189::US12454524, Example 189 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.490 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477841 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477841&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508292 442137455 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391868 CCn1c(CO)nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H18ClF2N5O3/c1-2-29-18(11-30)27-17-10-12(9-15(19(17)29)16-7-8-25-28-16)20(31)26-13-3-5-14(6-4-13)32-21(22,23)24/h3-10,30H,2,11H2,1H3,(H,25,28)(H,26,31) YCMTUADMXXSIJW-UHFFFAOYSA-N 477842 US10889571, Example 190::US20240101536, Example 190::US12240835, Example 190::US12454524, Example 190 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.870 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477842 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477842&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507922 442137456 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391869 OC[C@@H]1COCc2nc3cc(cc(-c4cccnn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-16-5-3-14(4-6-16)28-22(33)13-8-17(18-2-1-7-27-30-18)21-19(9-13)29-20-12-34-11-15(10-32)31(20)21/h1-9,15,32H,10-12H2,(H,28,33) WUODGACGVWSLTP-UHFFFAOYSA-N 477843 US10889571, Example 191::US20240101536, Example 191::US12240835, Example 191::US12454524, Example 191 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.460 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477843&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507924 442137457 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391870 C[C@H](C(F)F)n1cnc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF4N5O2/c1-12(20(24)25)32-11-28-18-10-13(9-16(19(18)32)17-3-2-8-29-31-17)21(33)30-14-4-6-15(7-5-14)34-22(23,26)27/h2-12,20H,1H3,(H,30,33) HOAVJABVPZNMII-UHFFFAOYSA-N 477844 US10889571, Example 192::US20240101536, Example 192::US12240835, Example 192::US12454524, Example 192 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.620 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477844&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507859 442137458 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391871 CC(C)n1c(nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C23H18ClF4N5O2/c1-12(2)33-19-16(17-4-3-9-29-32-17)10-13(11-18(19)31-21(33)20(25)26)22(34)30-14-5-7-15(8-6-14)35-23(24,27)28/h3-12,20H,1-2H3,(H,30,34) VBGXJIKIBGJDQO-UHFFFAOYSA-N 477845 US10889571, Example 193::US20240101536, Example 193::US12240835, Example 193::US12454524, Example 193 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.530 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477845&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507863 442137459 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391872 CCn1c(nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F InChI=1S/C22H16ClF4N5O2/c1-2-32-18-15(16-4-3-9-28-31-16)10-12(11-17(18)30-20(32)19(24)25)21(33)29-13-5-7-14(8-6-13)34-22(23,26)27/h3-11,19H,2H2,1H3,(H,29,33) IBEOJVOUGSZPPG-UHFFFAOYSA-N 477846 US10889571, Example 194::US20240101536, Example 194::US12240835, Example 194::US12454524, Example 194 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.570 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477846&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508291 442137460 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391873 CCn1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@H](C)O |r| InChI=1S/C23H20ClF2N5O3/c1-3-31-20-18(15-10-27-12-28-11-15)8-14(9-19(20)30-21(31)13(2)32)22(33)29-16-4-6-17(7-5-16)34-23(24,25)26/h4-13,32H,3H2,1-2H3,(H,29,33) NTZNUGKAAHONQH-UHFFFAOYSA-N 477847 US10889571, Example 195::US20240101536, Example 195::US12240835, Example 195::US12454524, Example 195 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.540 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477847&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507876 442137461 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391874 CCn1c(nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@H](C)O |r| InChI=1S/C23H20ClF2N5O3/c1-3-31-20-17(18-5-4-10-27-30-18)11-14(12-19(20)29-21(31)13(2)32)22(33)28-15-6-8-16(9-7-15)34-23(24,25)26/h4-13,32H,3H2,1-2H3,(H,28,33) KHXCKVMVESOBHB-UHFFFAOYSA-N 477848 US10889571, Example 196::US20240101536, Example 196::US12240835, Example 196::US12454524, Example 196 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.440 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477848&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508296 442137462 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391875 C[C@@H]1COCc2nc3cc(cc(N4CCC4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H21ClF2N4O3/c1-13-11-31-12-19-27-17-9-14(10-18(20(17)29(13)19)28-7-2-8-28)21(30)26-15-3-5-16(6-4-15)32-22(23,24)25/h3-6,9-10,13H,2,7-8,11-12H2,1H3,(H,26,30) IIPBAFNASZHPMY-UHFFFAOYSA-N 477849 US10889571, Example 197::US20240101536, Example 197::US12240835, Example 197::US12454524, Example 197 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 2.37 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477849&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507883 442137463 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391876 CC(C)n1c(nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@H](C)O |r| InChI=1S/C24H22ClF2N5O3/c1-13(2)32-21-19(16-10-28-12-29-11-16)8-15(9-20(21)31-22(32)14(3)33)23(34)30-17-4-6-18(7-5-17)35-24(25,26)27/h4-14,33H,1-3H3,(H,30,34) CVNJJTDTADCKKG-UHFFFAOYSA-N 477850 US10889571, Example 198::US20240101536, Example 198::US12240835, Example 198::US12454524, Example 198 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.470 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477850&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507878 442137464 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391877 CC(C)n1c(nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@H](C)O |r| InChI=1S/C24H22ClF2N5O3/c1-13(2)32-21-18(19-5-4-10-28-31-19)11-15(12-20(21)30-22(32)14(3)33)23(34)29-16-6-8-17(9-7-16)35-24(25,26)27/h4-14,33H,1-3H3,(H,29,34) CHCMCMRMXZSIER-UHFFFAOYSA-N 477851 US10889571, Example 199::US20240101536, Example 199::US12240835, Example 199::US12454524, Example 199 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.470 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477851&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507915 442137465 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391878 OC[C@@H]1COc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF2N5O4/c23-22(24,25)34-16-3-1-14(2-4-16)28-20(32)12-5-17(13-7-26-11-27-8-13)19-18(6-12)29-21-30(19)15(9-31)10-33-21/h1-8,11,15,31H,9-10H2,(H,28,32) JCFUICBDQGMFFE-UHFFFAOYSA-N 477852 US10889571, Example 200::US20240101536, Example 200::US12240835, Example 200::US12454524, Example 200 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.480 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477852&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508293 442137466 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391879 FC(F)Cn1cnc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H14ClF4N5O2/c22-21(25,26)33-14-5-3-13(4-6-14)29-20(32)12-8-15(16-2-1-7-28-30-16)19-17(9-12)27-11-31(19)10-18(23)24/h1-9,11,18H,10H2,(H,29,32) UXXFHESWLVJWQI-UHFFFAOYSA-N 477853 US10889571, Example 201::US20240101536, Example 201::US12240835, Example 201::US12454524, Example 201 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.490 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477853&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509067 442137467 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391880 O[C@@H]1CCCn2c1nc1cc(cc(-c3cncnc3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-16-5-3-15(4-6-16)29-22(33)13-8-17(14-10-27-12-28-11-14)20-18(9-13)30-21-19(32)2-1-7-31(20)21/h3-6,8-12,19,32H,1-2,7H2,(H,29,33) AYXCCWLMARXDTG-UHFFFAOYSA-N 477854 US10889571, Example 202::US20240101536, Example 202::US12240835, Example 202::US12454524, Example 202 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.660 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477854 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477854&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508294 442137468 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391881 C[C@@H]1COCc2nc3cc(cc(-c4cc(n[nH]4)C4CC4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C25H22ClF2N5O3/c1-13-11-35-12-22-30-21-9-15(24(34)29-16-4-6-17(7-5-16)36-25(26,27)28)8-18(23(21)33(13)22)20-10-19(31-32-20)14-2-3-14/h4-10,13-14H,2-3,11-12H2,1H3,(H,29,34)(H,31,32) CBOXVYADDTUDDB-UHFFFAOYSA-N 477855 US10889571, Example 203::US20240101536, Example 203::US12240835, Example 203::US12454524, Example 203 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.770 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477855 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477855&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507866 442137469 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391882 O[C@H]1CCc2nc3cc(cc(-c4cccnn4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-16-6-3-14(4-7-16)28-22(33)13-10-17(18-2-1-9-27-30-18)21-19(11-13)29-20-8-5-15(32)12-31(20)21/h1-4,6-7,9-11,15,32H,5,8,12H2,(H,28,33) VBSJCLFQIJAKJT-UHFFFAOYSA-N 477856 US10889571, Example 204::US20240101536, Example 204::US12240835, Example 204::US12454524, Example 204 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.410 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477856 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477856&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508300 442137470 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391883 C[C@H](CF)n1c(nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)C(F)F |r| InChI=1S/C23H17ClF5N5O2/c1-12(11-25)34-19-16(17-3-2-8-30-33-17)9-13(10-18(19)32-21(34)20(26)27)22(35)31-14-4-6-15(7-5-14)36-23(24,28)29/h2-10,12,20H,11H2,1H3,(H,31,35) VFDCNEAHEVWDHI-UHFFFAOYSA-N 477857 US10889571, Example 205::US20240101536, Example 205::US12240835, Example 205::US12454524, Example 205 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.970 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477857 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477857&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507927 442137471 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391884 C[C@H](CO)n1cnc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O3/c1-13(11-31)30-12-26-19-10-14(9-17(20(19)30)18-3-2-8-27-29-18)21(32)28-15-4-6-16(7-5-15)33-22(23,24)25/h2-10,12-13,31H,11H2,1H3,(H,28,32) AEHUMGLWFAMHEX-UHFFFAOYSA-N 477858 US10889571, Example 206::US20240101536, Example 206::US12240835, Example 206::US12454524, Example 206 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.550 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477858 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477858&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508301 442137472 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391885 OC[C@@H]1COc2nc3cc(cc(-c4cccnn4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF2N5O4/c23-22(24,25)34-15-5-3-13(4-6-15)27-20(32)12-8-16(17-2-1-7-26-29-17)19-18(9-12)28-21-30(19)14(10-31)11-33-21/h1-9,14,31H,10-11H2,(H,27,32) NWKZUUBGZLTBSL-UHFFFAOYSA-N 477859 US10889571, Example 207::US20240101536, Example 207::US12240835, Example 207::US12454524, Example 207 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.41 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477859&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509061 442137473 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391886 O[C@H]1CCn2c(C1)nc1cc(cc(-c3cncnc3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-17-3-1-15(2-4-17)29-22(33)13-7-18(14-10-27-12-28-11-14)21-19(8-13)30-20-9-16(32)5-6-31(20)21/h1-4,7-8,10-12,16,32H,5-6,9H2,(H,29,33) PEULMECLCHWIRA-UHFFFAOYSA-N 477860 US10889571, Example 208::US20240101536, Example 208::US12240835, Example 208::US12454524, Example 208 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.370 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477860 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477860&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507920 442137474 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391887 O[C@@H]1CCn2c(C1)nc1cc(cc(-c3cncnc3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-17-3-1-15(2-4-17)29-22(33)13-7-18(14-10-27-12-28-11-14)21-19(8-13)30-20-9-16(32)5-6-31(20)21/h1-4,7-8,10-12,16,32H,5-6,9H2,(H,29,33) PEULMECLCHWIRA-UHFFFAOYSA-N 477861 US10889571, Example 209::US20240101536, Example 209::US12240835, Example 209::US12454524, Example 209 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.450 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477861 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477861&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507882 442137475 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391888 O[C@H]1CCn2c(C1)nc1cc(cc(-c3cccnn3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-16-5-3-14(4-6-16)28-22(33)13-10-17(18-2-1-8-27-30-18)21-19(11-13)29-20-12-15(32)7-9-31(20)21/h1-6,8,10-11,15,32H,7,9,12H2,(H,28,33) UOZHXPYTDHEBHI-UHFFFAOYSA-N 477862 US10889571, Example 210::US20240101536, Example 210::US12240835, Example 210::US12454524, Example 210 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.510 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477862 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477862&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507870 442137476 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391889 O[C@@H]1CCn2c(C1)nc1cc(cc(-c3cccnn3)c21)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-16-5-3-14(4-6-16)28-22(33)13-10-17(18-2-1-8-27-30-18)21-19(11-13)29-20-12-15(32)7-9-31(20)21/h1-6,8,10-11,15,32H,7,9,12H2,(H,28,33) UOZHXPYTDHEBHI-UHFFFAOYSA-N 477863 US10889571, Example 211::US20240101536, Example 211::US12240835, Example 211::US12454524, Example 211 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.550 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477863 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477863&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508303 442137477 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391890 CCn1c(OC)nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O3/c1-3-30-19-16(17-5-4-10-26-29-17)11-13(12-18(19)28-21(30)32-2)20(31)27-14-6-8-15(9-7-14)33-22(23,24)25/h4-12H,3H2,1-2H3,(H,27,31) UMZYQHCANUJSDR-UHFFFAOYSA-N 477864 US10889571, Example 212::US20240101536, Example 212::US12240835, Example 212::US12454524, Example 212 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.730 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477864 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477864&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507864 442137478 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391891 CCn1c(OC)nc2cc(cc(-c3ccn[nH]3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C21H18ClF2N5O3/c1-3-29-18-15(16-8-9-25-28-16)10-12(11-17(18)27-20(29)31-2)19(30)26-13-4-6-14(7-5-13)32-21(22,23)24/h4-11H,3H2,1-2H3,(H,25,28)(H,26,30) NSTRBEVJQFNPQT-UHFFFAOYSA-N 477865 US10889571, Example 213::US20240101536, Example 213::US12240835, Example 213::US12454524, Example 213 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.440 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477865 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477865&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507862 442137479 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391892 CCn1c(nc2cc(cc(-c3cnoc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1)[C@H](C)O |r| InChI=1S/C22H19ClF2N4O4/c1-3-29-19-17(14-10-26-32-11-14)8-13(9-18(19)28-20(29)12(2)30)21(31)27-15-4-6-16(7-5-15)33-22(23,24)25/h4-12,30H,3H2,1-2H3,(H,27,31) WFSQDNAYBGKJLP-UHFFFAOYSA-N 477866 US10889571, Example 214::US20240101536, Example 214::US12240835, Example 214::US12454524, Example 214 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.450 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477866 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477866&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507854 442137480 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391893 O[C@H]1CCc2nc3cc(cc(-c4cnoc4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O4/c23-22(24,25)33-16-4-1-14(2-5-16)27-21(31)12-7-17(13-9-26-32-11-13)20-18(8-12)28-19-6-3-15(30)10-29(19)20/h1-2,4-5,7-9,11,15,30H,3,6,10H2,(H,27,31) WLEMJLVRHBAXOK-UHFFFAOYSA-N 477867 US10889571, Example 215::US20240101536, Example 215::US12240835, Example 215::US12454524, Example 215 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.03 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477867 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477867&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508274 442137481 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391894 C[C@@H]1[C@H](O)COc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O4/c1-11-18(31)10-33-21-28-17-9-12(8-15(19(17)30(11)21)16-6-7-26-29-16)20(32)27-13-2-4-14(5-3-13)34-22(23,24)25/h2-9,11,18,31H,10H2,1H3,(H,26,29)(H,27,32) FTBLTAUWCBGOCO-UHFFFAOYSA-N 477868 US10889571, Example 216::US20240101536, Example 216::US12240835, Example 216::US12454524, Example 216 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.990 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477868 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477868&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 147563359 442137482 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391895 OC[C@@H]1CCOc2nc3cc(cc(-c4cncnc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-17-3-1-15(2-4-17)29-21(33)13-7-18(14-9-27-12-28-10-14)20-19(8-13)30-22-31(20)16(11-32)5-6-34-22/h1-4,7-10,12,16,32H,5-6,11H2,(H,29,33) UBXJFHOGQFPNSR-UHFFFAOYSA-N 477869 US10889571, Example 217::US20240101536, Example 217::US12240835, Example 217::US12454524, Example 217 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.560 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477869 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477869&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508298 442137483 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391896 CCn1c(OC)nc2cc(cc(-c3cncnc3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 InChI=1S/C22H18ClF2N5O3/c1-3-30-19-17(14-10-26-12-27-11-14)8-13(9-18(19)29-21(30)32-2)20(31)28-15-4-6-16(7-5-15)33-22(23,24)25/h4-12H,3H2,1-2H3,(H,28,31) VFXYTVJSDPFXQO-UHFFFAOYSA-N 477870 US10889571, Example 218::US20240101536, Example 218::US12240835, Example 218::US12454524, Example 218 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.340 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477870 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477870&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507886 442137484 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391897 C[C@@H]1CCOc2nc3cc(cc(-c4cnoc4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H17ClF2N4O4/c1-12-6-7-31-21-28-18-9-13(8-17(19(18)29(12)21)14-10-26-32-11-14)20(30)27-15-2-4-16(5-3-15)33-22(23,24)25/h2-5,8-12H,6-7H2,1H3,(H,27,30) QAHBJZRKVXZYMG-UHFFFAOYSA-N 477871 US10889571, Example 219::US20240101536, Example 219::US12240835, Example 219::US12454524, Example 219 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.930 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477871 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477871&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508302 442137485 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391898 OCC[C@H]1COc2nc3cc(cc(-c4ccn[nH]4)c3n12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H18ClF2N5O4/c23-22(24,25)34-15-3-1-13(2-4-15)27-20(32)12-9-16(17-5-7-26-29-17)19-18(10-12)28-21-30(19)14(6-8-31)11-33-21/h1-5,7,9-10,14,31H,6,8,11H2,(H,26,29)(H,27,32) MMEYQBQZXGSZEL-UHFFFAOYSA-N 477872 US10889571, Example 220::US20240101536, Example 220::US12240835, Example 220::US12454524, Example 220 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 2.55 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477872 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477872&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509076 442137486 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391899 COc1nc2cc(cc(-c3cncnc3)c2n1[C@H](C)CO)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O4/c1-13(11-32)31-20-18(15-9-27-12-28-10-15)7-14(8-19(20)30-22(31)34-2)21(33)29-16-3-5-17(6-4-16)35-23(24,25)26/h3-10,12-13,32H,11H2,1-2H3,(H,29,33) KWUSWWVUFCSAJF-UHFFFAOYSA-N 477873 US10889571, Example 221::US20240101536, Example 221::US12240835, Example 221::US12454524, Example 221 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.280 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477873 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477873&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509075 442137487 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391900 C[C@H](CO)n1c(C)nc2cc(cc(-c3cccnn3)c12)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O3/c1-13(12-32)31-14(2)28-20-11-15(10-18(21(20)31)19-4-3-9-27-30-19)22(33)29-16-5-7-17(8-6-16)34-23(24,25)26/h3-11,13,32H,12H2,1-2H3,(H,29,33) WDDWJULWDGKQMB-UHFFFAOYSA-N 477874 US10889571, Example 222::US20240101536, Example 222::US12240835, Example 222::US12454524, Example 222 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.670 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477874 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477874&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509078 442137488 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391901 COc1nc2cc(cc(-c3ccn[nH]3)c2n1[C@H](C)CO)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H20ClF2N5O4/c1-12(11-31)30-19-16(17-7-8-26-29-17)9-13(10-18(19)28-21(30)33-2)20(32)27-14-3-5-15(6-4-14)34-22(23,24)25/h3-10,12,31H,11H2,1-2H3,(H,26,29)(H,27,32) IUTWRYMBWXMOTM-UHFFFAOYSA-N 477875 US10889571, Example 223::US20240101536, Example 223::US12240835, Example 223::US12454524, Example 223 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 0.260 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477875 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477875&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507867 442137489 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391902 COc1nc2cc(cc(-c3cccnn3)c2n1[C@H](C)CO)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C23H20ClF2N5O4/c1-13(12-32)31-20-17(18-4-3-9-27-30-18)10-14(11-19(20)29-22(31)34-2)21(33)28-15-5-7-16(8-6-15)35-23(24,25)26/h3-11,13,32H,12H2,1-2H3,(H,28,33) ZYGVPBDGRITBEV-UHFFFAOYSA-N 477876 US10889571, Example 224::US20240101536, Example 224::US12240835, Example 224::US12454524, Example 224 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 1.000 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477876 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477876&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508299 442137490 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391903 O[C@H]1COc2nc3cc(cc(-c4ccn[nH]4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C21H16ClF2N5O4/c22-21(23,24)33-14-3-1-12(2-4-14)26-19(31)11-7-15(16-5-6-25-28-16)18-17(8-11)27-20-29(18)9-13(30)10-32-20/h1-8,13,30H,9-10H2,(H,25,28)(H,26,31) JINCZJLUPRREFO-UHFFFAOYSA-N 477877 US10889571, Example 225::US20240101536, Example 225::US12240835, Example 225::US12454524, Example 225 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 8.71 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477877&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146508304 442137491 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391904 O[C@H]1COc2nc3cc(cc(-c4cccnn4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF2N5O4/c23-22(24,25)34-15-5-3-13(4-6-15)27-20(32)12-8-16(17-2-1-7-26-29-17)19-18(9-12)28-21-30(19)10-14(31)11-33-21/h1-9,14,31H,10-11H2,(H,27,32) QFSZDFHZGFEPAP-UHFFFAOYSA-N 477878 US10889571, Example 226::US20240101536, Example 226::US12240835, Example 226::US12454524, Example 226 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 28.0 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477878&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146509077 442137492 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09 1391905 O[C@H]1COc2nc3cc(cc(-c4cncnc4)c3n2C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |r| InChI=1S/C22H16ClF2N5O4/c23-22(24,25)34-16-3-1-14(2-4-16)28-20(32)12-5-17(13-7-26-11-27-8-13)19-18(6-12)29-21-30(19)9-15(31)10-33-21/h1-8,11,15,31H,9-10H2,(H,28,32) ACTPPPZUVGZQQF-UHFFFAOYSA-N 477879 US10889571, Example 227::US20240101536, Example 227::US12240835, Example 227::US12454524, Example 227 Tyrosine-protein kinase ABL1 [64-515] Homo sapiens 9.67 US Patent 10.7270/Q2Q244J5 aid1963540 US20240101536 ROMERO, FA; KIRSCHBERG, TA; HALCOMB, R; XU, Y 3/28/2024 6/11/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=610&target=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477879&enzyme=Tyrosine-protein+kinase+ABL1+%5B64-515%5D&column=ki&startPg=0&Increment=50&submit=Search 146507855 442137493 1 NLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGV 8SSN,6XR7,6XR6,2E2B,6NPV,6NPU,6NPE,3PYY,4ZOG,3OXZ,7DT2,7CC2,7W7Y,2HZ4,2HYY,8I7Z,8I7T,8I7S,7W7X,3CS9,2HZI,2GQG,3QRK,3QRI,7N9G,2HZ0,2ABL,5DC0,5DC9,5DC4,3UYO,3T04 Tyrosine-protein kinase ABL1 ABL1_HUMAN P00519 A3KFJ3 Q13869 Q13870 Q16133 Q17R61 Q45F09